<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">76766</article-id><article-id pub-id-type="doi">10.7554/eLife.76766</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Crystal structures of bacterial small multidrug resistance transporter EmrE in complex with structurally diverse substrates</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-168694"><name><surname>Kermani</surname><given-names>Ali A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-266508"><name><surname>Burata</surname><given-names>Olive E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8450-8930</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235490"><name><surname>Koff</surname><given-names>B Ben</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3276-143X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199739"><name><surname>Koide</surname><given-names>Akiko</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-199740"><name><surname>Koide</surname><given-names>Shohei</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" corresp="yes" id="author-165878"><name><surname>Stockbridge</surname><given-names>Randy B</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8848-3032</contrib-id><email>stockbr@umich.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf4"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jmfr291</institution-id><institution>Department of Molecular, Cellular, and Developmental Biology, University of Michigan</institution></institution-wrap><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jmfr291</institution-id><institution>Program in Chemical Biology, University of Michigan</institution></institution-wrap><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/005dvqh91</institution-id><institution>Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0190ak572</institution-id><institution>Department of Medicine, New York University Grossman School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0190ak572</institution-id><institution>Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jmfr291</institution-id><institution>Program in Biophysics, University of Michigan</institution></institution-wrap><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ben-Tal</surname><given-names>Nir</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04mhzgx49</institution-id><institution>Tel Aviv University</institution></institution-wrap><country>Israel</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cvxnb49</institution-id><institution>Goethe University</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>07</day><month>03</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e76766</elocation-id><history><date date-type="received" iso-8601-date="2022-01-04"><day>04</day><month>01</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-03-06"><day>06</day><month>03</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-01-11"><day>11</day><month>01</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.01.11.475788"/></event></pub-history><permissions><copyright-statement>© 2022, Kermani et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Kermani et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-76766-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-76766-figures-v2.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="commentary" xlink:href="10.7554/eLife.78504"/><abstract><p>Proteins from the bacterial small multidrug resistance (SMR) family are proton-coupled exporters of diverse antiseptics and antimicrobials, including polyaromatic cations and quaternary ammonium compounds. The transport mechanism of the <italic>Escherichia coli</italic> transporter, EmrE, has been studied extensively, but a lack of high-resolution structural information has impeded a structural description of its molecular mechanism. Here, we apply a novel approach, multipurpose crystallization chaperones, to solve several structures of EmrE, including a 2.9 Å structure at low pH without substrate. We report five additional structures in complex with structurally diverse transported substrates, including quaternary phosphonium, quaternary ammonium, and planar polyaromatic compounds. These structures show that binding site tryptophan and glutamate residues adopt different rotamers to conform to disparate structures without requiring major rearrangements of the backbone structure. Structural and functional comparison to Gdx-Clo, an SMR protein that transports a much narrower spectrum of substrates, suggests that in EmrE, a relatively sparse hydrogen bond network among binding site residues permits increased sidechain flexibility.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>transporter</kwd><kwd>antiseptic resistance</kwd><kwd>crystallography</kwd><kwd>qac</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>CA194864</award-id><principal-award-recipient><name><surname>Koide</surname><given-names>Shohei</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>CAREER 1845012</award-id><principal-award-recipient><name><surname>Stockbridge</surname><given-names>Randy B</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000861</institution-id><institution>Burroughs Wellcome Fund</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Stockbridge</surname><given-names>Randy B</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>In the bacterial small multidrug transporter EmrE, sidechain rearrangements in the binding site accommodate structurally diverse substrates without major rearrangements of the protein backbone.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The small multidrug resistance (SMR) family of microbial membrane proteins is a well-studied family composed of primitive dual-topology proton-coupled transporters. The SMR family has two major physiological subtypes that can be distinguished based on sequence (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>). Representatives of the ‘Gdx’ (<underline>g</underline>uani<underline>d</underline>inium e<underline>x</underline>port) subtype export a bacterial metabolite, guanidinium ion (Gdm<sup>+</sup>), in exchange for two protons (<xref ref-type="bibr" rid="bib22">Kermani et al., 2018</xref>; <xref ref-type="bibr" rid="bib38">Nelson et al., 2017</xref>). Representatives of the ‘Qac’ (<underline>q</underline>uaternary <underline>a</underline>mmonium <underline>c</underline>ompound) subtype are proton-coupled exchangers of quaternary ammoniums and other hydrophobic, cationic compounds. Since the first quaternary ammonium antiseptics were introduced approximately one hundred years ago, proteins from the Qac cluster have been closely associated with the spread of multidrug resistance elements (<xref ref-type="bibr" rid="bib18">Gillings, 2017</xref>; <xref ref-type="bibr" rid="bib40">Pal et al., 2015</xref>; <xref ref-type="bibr" rid="bib44">Russell, 2002</xref>; <xref ref-type="bibr" rid="bib62">Zhu et al., 2017</xref>).</p><p>Many bacteria possess SMR proteins belonging to both subtypes. Transporters from the Qac and Gdx clusters do not overlap in terms of physiological role: the Qac proteins do not transport Gdm<sup>+</sup> and require additional hydrophobicity in transported substrates, whereas the Gdx transporters require substrates to have a guanidinyl moiety and cannot export quaternary ammoniums or other cations (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>). However, the two subtypes transport an overlapping subset of hydrophobic substituted guanidinium ions and share high sequence conservation (~35% sequence identity), strongly suggesting conservation of the overall fold.</p><p>The best-studied of the Qac proteins is the <italic>E. coli</italic> member, EmrE. The substrate repertoire of EmrE includes planar, conjugated aromatic ring systems, quaternary ammoniums and phosphoniums (with or without aromatic substituents), and substituted guanidiniums. EmrE also provides resistance to biocides from these substrate classes with long alkyl tails, such as benzalkonium and cetyltrimethylammonium, which are found in common household antiseptics. Mechanisms to explain the transport promiscuity have been proposed, typically focusing on protein dynamics as a feature that allows it to transport many different substrates (<xref ref-type="bibr" rid="bib21">Jurasz et al., 2021</xref>; <xref ref-type="bibr" rid="bib41">Robinson et al., 2017</xref>). However, the structural basis for substrate binding is unknown, and for many years, structural information was limited to low-resolution models without loops or sidechains (<xref ref-type="bibr" rid="bib16">Fleishman et al., 2006</xref>; <xref ref-type="bibr" rid="bib54">Ubarretxena-Belandia et al., 2003</xref>), impeding a full description of the molecular mechanism. A previous crystal structure of EmrE was unreliable for molecular analysis, with no sidechains modeled, poor helical geometry, and helices too short to span the membrane (<xref ref-type="bibr" rid="bib10">Chen et al., 2007</xref>). Computational models constrained by the low-resolution data have also been proposed (<xref ref-type="bibr" rid="bib39">Ovchinnikov et al., 2018</xref>; <xref ref-type="bibr" rid="bib55">Vermaas et al., 2018</xref>). Recently, high-resolution structural information for the SMR family has begun to emerge. First, crystal structures of a Gdx homologue from <italic>Clostridales</italic>, Gdx-Clo, were resolved in complex with substituted guanidinium compounds including octylguanidinium (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>). In addition to revealing the binding mode of the guanidinyl headgroup, the structure of Gdx-Clo with octylguanidinium showed that hydrophobic repacking of residues lining one side of the binding pocket opens a portal from the substrate binding site to the membrane interior, accommodating the substrate’s long alkyl tail. In addition, a model of an EmrE mutant with reduced conformational exchange dynamics, S64V, computed from extensive NMR measurements, was also reported recently (<xref ref-type="bibr" rid="bib48">Shcherbakov et al., 2021</xref>).</p><p>Here, we report several crystal structures of EmrE, including a low-pH (proton-bound) structure and five structures in complex with structurally diverse quaternary phosphonium, quaternary ammonium, and planar aromatic substrates. Structure determination was facilitated by repurposing a monobody crystallization chaperone that we originally developed for Gdx-Clo (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>). The EmrE structure reported here has high structural similarity to Gdx-Clo, but with notable differences in the hydrogen bond network of the substrate-binding site. The various substrates are accommodated by EmrE with minimal changes in the backbone structure. Instead, binding site tryptophan and glutamate sidechains adopt different rotamers to accommodate different drugs. These sidechain motions expand or reduce the binding pocket and provide ring-stacking interactions for structurally disparate substrates. We propose that, compared with the closely related but more selective SMR, Gdx-Clo, a reduced network of hydrogen bond interactions in the EmrE binding site allows sidechain flexibility to accommodate polyaromatics, substituted guanidinyl compounds, and quaternary ammoniums and phosphoniums without requiring substantial alteration of EmrE’s backbone configuration.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Engineering of EmrE to introduce a monobody binding site</title><p>We recently solved a crystal structure of a metabolic Gdm<sup>+</sup> exporter from the SMR family, Gdx-Clo (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>). For this effort, we selected monobody crystallization chaperones from large combinatorial libraries (<xref ref-type="bibr" rid="bib25">Koide et al., 2012</xref>; <xref ref-type="bibr" rid="bib47">Sha et al., 2017</xref>), which aided in crystallization of the transporter. Upon structure determination, we noticed that the interface between Gdx-Clo and monobody L10 is limited to a nine-residue stretch of loop one that is relatively well-conserved among SMR proteins (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Moreover, crystal contacts are mediated almost entirely by the monobody, whereas contacts between the transporter and a symmetry mate are limited to five hydrophobic residues contributed by TM4<sub>A</sub> and TM4<sub>B</sub> (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). These observations suggested that conservative mutagenesis of EmrE loop one to introduce the Gdx-Clo residues might permit monobody L10 binding in order to facilitate crystallization of EmrE. We therefore designed a triple mutant, E25N, W31I, V34M, which we call EmrE<sub>3</sub>. Previous studies showed minimal functional perturbation upon mutation of E25 and W31 to Ala or Cys (<xref ref-type="bibr" rid="bib14">Elbaz et al., 2005</xref>; <xref ref-type="bibr" rid="bib61">Yerushalmi and Schuldiner, 2000</xref>). All three residues are located at a distance from the substrate-binding site, and none of the three are conserved in the SMR family.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Introduction of monobody binding epitope to EmrE.</title><p>(<bold>A</bold>) Sequence alignment for loop 1 of selected SMR proteins, numbered according to EmrE sequence. From top to bottom: representative Gdx sequences (<italic>Clostridiales</italic> bacterium oral taxon 876, <italic>Escherichia coli</italic>, <italic>Micromonospora</italic>, <italic>Streptomyces tsukubensis</italic>, and <italic>Leifsonia aquatica</italic>) and representative Qac sequences (<italic>Escherichia coli</italic>, <italic>Klebsiella pneumoniae</italic>, <italic>Pseudomonas aeruginosa</italic>, <italic>Mycobacterium bovis</italic>, and <italic>Bordetella avium</italic>). Positions mutated in the EmrE<sub>3</sub> construct (E25N, W31I, V34M) are indicated with red asterisks. Sequence conservation analysis for this loop is shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>. (<bold>B</bold>) Representative currents evoked by perfusion of WT EmrE or EmrE<sub>3</sub> sensors (shades of red and blue, respectively) with 30 μM – 3 mM TPA<sup>+</sup> (top panels) or PheGdm<sup>+</sup> (Phe, lower panels). Insets show plot of peak current amplitude as a function of substrate concentration for a representative titration performed using a single sensor. Solid lines represent fit of datapoints from a single titration series to the Michaelis-Menten equation. K<sub>m</sub> values for independent replicates are reported in <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>. (<bold>C</bold>) Microscale thermophoresis measurement of EmrE<sub>3</sub> binding to monobody L10. Points and error bars represent mean and SEM of three independently prepared samples. Where not visible, error bars are smaller than the diameter of the point. Dashed line represents fit to <xref ref-type="disp-formula" rid="equ1">Equation 1</xref> with K<sub>d</sub> = 850 nM. Representative raw data trace is shown in <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>. (<bold>D</bold>) EmrE<sub>3</sub> currents evoked by 1 mM PheGdm<sup>+</sup>. Sensors were incubated for 10 min in the presence (red traces) or absence (blue traces) 10 μM monobody L10 prior to initiating transport by perfusion with PheGdm<sup>+</sup>. Currents shown are from a representative experimental series using a single sensor preparation. (<bold>E</bold>) Peak currents measured for three independent perfusion series performed as in panel D. Peak currents decreased an average of 40% ± 1.5% in the presence of monobody.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>SSM electrophysiology traces for EmrE and EmrE<sub>3</sub> with varying concentrations of TPA<sup>+</sup> and phenylGdm<sup>+</sup>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-76766-fig1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Peak currents for EmrE or EmrE<sub>3</sub> as a function of TPA<sup>+</sup> or phenylGdm<sup>+</sup> concentration.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-76766-fig1-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Changes in MST fluorescence as a function of EmrE<sub>3</sub> concentration.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-76766-fig1-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata4"><label>Figure 1—source data 4.</label><caption><title>SSM electrophysiology traces for EmrE<sub>3</sub> with and without L10 monobody addition.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-76766-fig1-data4-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata5"><label>Figure 1—source data 5.</label><caption><title>Peak current values for replicate measurements of EmrE<sub>3</sub> currents in the presence and absence of monobody L10.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-76766-fig1-data5-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata6"><label>Figure 1—source data 6.</label><caption><title>K<sub>m</sub> values for TPA<sup>+</sup> and phenylGdm<sup>+</sup> transport by EmrE and EmrE<sub>3</sub>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-76766-fig1-data6-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Crystal lattice for Gdx-Clo/L10 monobody complex (PDB: 6WK8).</title><p>The asymmetric unit, composed of one Gdx-Clo dimer and two monobodies, is shown in cyan. Symmetry mates are shown in gray. Residues that contribute to an interface between the asymmetric unit and its symmetry mates are colored yellow. Five Gdx-Clo residues are in contact with a symmetry mate: TM4 residues V88<sub>B</sub>, L92<sub>B</sub>, T95<sub>B</sub>, F89<sub>A</sub>, L92<sub>A</sub> (dashed red box).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>K<sub>m</sub> values for TPA<sup>+</sup> and PheGdm<sup>+</sup> transport by EmrE<sub>3</sub> (blue) and WT EmrE (red).</title><p>Individual points are derived from Michaelis-Menten fits of titration experiments performed on a single sensor. Each Km value was measured from a full titration series on an independently prepared sensor. Sensors are prepared from two to three independent biochemical purifications.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Representative microscale thermophoresis traces for monobody L10 in the presence of 30 nM – 10 μM EmrE<sub>3</sub>.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig1-figsupp3-v2.tif"/></fig></fig-group><p>In accord with these observations, solid supported membrane (SSM) electrophysiology experiments showed that EmrE<sub>3</sub> mutant is active and transports representative substrates tetrapropylammonium (TPA<sup>+</sup>) and phenylguanidinium (PheGdm<sup>+</sup>). Upon perfusion with substrate, negative capacitive currents are evoked, indicating an electrogenic transport cycle, with substrate transport coupled to the antiport of ~2 H<sup>+</sup>, as has been previously reported for these (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>) and other substrates (<xref ref-type="bibr" rid="bib1">Adam et al., 2007</xref>; <xref ref-type="bibr" rid="bib42">Rotem and Schuldiner, 2004</xref>; <xref ref-type="bibr" rid="bib49">Soskine et al., 2004</xref>). In SSM experiments, the peak capacitive current corresponds to the initial rate of substrate transport (<xref ref-type="bibr" rid="bib6">Bazzone et al., 2017</xref>). The SSM electrophysiology traces are very similar for WT EmrE and EmrE<sub>3</sub> (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Measurements of peak currents as a function of substrate concentration were fit to the Michaelis-Menten equation, yielding K<sub>m</sub> values within twofold of those measured for WT EmrE (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Microscale thermophoresis experiments show that EmrE<sub>3</sub> binds monobody L10 with a K<sub>d</sub> of 850 nM (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>), indicating that these small modifications at surface exposed residues were sufficient to create a monobody binding site. Similar to our observation for Gdx-Clo (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>), addition of saturating L10 monobody (10 μM) depresses transport currents mediated by EmrE<sub>3</sub> by about 40% but does not altogether inhibit substrate transport (<xref ref-type="fig" rid="fig1">Figure 1D and E</xref>). Currents are fully restored upon subsequent incubation with monobody-free solution. Thus, EmrE<sub>3</sub> is functionally equivalent to WT EmrE, is capable of binding monobody L10, and retains function when this monobody is bound.</p></sec><sec id="s2-2"><title>Structure of EmrE<sub>3</sub> without ligand at pH 5.2</title><p>When combined with monobody L10, EmrE<sub>3</sub> crystallized and diffracted to a maximum resolution of 2.9 Å. The crystallization conditions differed from those used for the Gdx-Clo/monobody complex, but the space group, C121, and approximate dimensions of the unit cell were the same (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>). We solved the structure using molecular replacement, with the L10 monobodies and the first three helices of each Gdx-Clo monomer as search models. After phasing, loop 3 and helix 4 were built into the experimental density followed by iterative rounds of refinement (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A,B</xref>). The model was validated by preparing a composite omit map in which 5% of the atoms in the model were removed at a time (<xref ref-type="bibr" rid="bib51">Terwilliger et al., 2008</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C,D</xref>). Our EmrE<sub>3</sub> model corresponds well with the composite omit maps, suggesting that model bias introduced by using Gdx-Clo as a molecular replacement search model does not unduly influence our model of EmrE<sub>3</sub>.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Crystal structure of EmrE<sub>3</sub>.</title><p>(<bold>A</bold>) Subunits A and B are shown in blue and orange, respectively, and monobody L10 is shown in gray. In the left panel, mutated residues E25N, W31I, V34M are shown in red with sidechain sticks. In the right panel, the monobodies are removed for clarity. E14<sub>A</sub>, E14<sub>B</sub>, and F27<sub>A</sub> are shown as sticks, and the aqueous accessible region of the transporter is indicated with dots. Approximate membrane boundaries are shown as solid lines, and the boundary of the membrane portal is shown as a dashed line. (<bold>B</bold>) A (blue) and B (orange) subunits of EmrE<sub>3</sub>, aligned over residues 1–63. The GVG fulcrum sequence in TM3 is colored in magenta. (<bold>C</bold>) S64 and surrounding sidechains with 2F<sub>o</sub>-F<sub>c</sub> density shown as gray mesh (contoured at 1.0 σ within 2 Å of selected residues). (<bold>D</bold>) Y60<sub>B</sub> hydrogen bonding network. EmrE dimers are shown with TM1 and TM2 of subunit B (orange) removed for clarity. Lower panels show zoomed in view. In each view, interactions within hydrogen bonding distance and geometry are shown as dashed lines. E. Surface rendering of EmrE<sub>3</sub>. TM2 sidechains that line the portal are shown as sticks.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>EmrE<sub>3</sub> maps.</title><p>Subunits colored as in main text, with subunit B in orange, and subunit A in blue. Panels A and B: 2F<sub>o</sub>-F<sub>c</sub> maps for EmrE<sub>3</sub>, contoured at 1.2σ. Panels C and D: 2F<sub>o</sub>-F<sub>c</sub> composite omit maps for EmrE<sub>3</sub>, contoured at 1.0σ, prepared by omitting 5% of the atoms in the model at a time.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Structural comparison of EmrE<sub>3</sub> crystal structure with electron microscopy maps, theoretical model, and Gdx-Clo.</title><p>(<bold>A</bold>) Crystal structure of EmrE<sub>3</sub> (orange and blue cartoon) overlaid with experimental electron microscopy (EM) density (cyan mesh contoured at 1.5σ) (<xref ref-type="bibr" rid="bib54">Ubarretxena-Belandia et al., 2003</xref>). (<bold>B</bold>) Crystal structure of EmrE<sub>3</sub> (orange and blue) compared to a computational model (yellow and cyan) constrained by EM data (<xref ref-type="bibr" rid="bib55">Vermaas et al., 2018</xref> ). (<bold>C</bold>) Crystal structure of EmrE<sub>3</sub> (orange and blue) compared to crystal structure of a homologue from the SMR family, Gdx-Clo (wheat and pale cyan) (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>). Models are aligned along the B subunit.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Sidechain density in the EmrE<sub>3</sub> binding site.</title><p>2F<sub>o</sub>-F<sub>c</sub> map around selected residues is contoured at 1.5 σ. The red sphere represents a water molecule.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig2-figsupp3-v2.tif"/></fig></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Data collection, phasing, and refinement statistics for EmrE and Gdx-Clo complexes.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="center" valign="bottom">EmrE<sub>3</sub>/L10/MeTPP<sup>+</sup></th><th align="center" valign="bottom">EmrE<sub>3</sub>/L10/TPP<sup>+</sup></th><th align="center" valign="bottom">EmrE<sub>3</sub>/L10/harmane</th><th align="center" valign="bottom">EmrE<sub>3</sub>/L10/methyl viologen</th><th align="center" valign="bottom">EmrE<sub>3</sub>/L10, pH 5.2</th><th align="center" valign="bottom">Gdx-Clo/L10, pH 5.0</th><th align="center" valign="bottom">EmrE<sub>3</sub>/L10/BM<sub>3</sub>A<sup>+</sup></th></tr></thead><tbody><tr><td align="left" valign="bottom"><bold>Crystallization conditions</bold></td><td align="left" valign="bottom">0.1 M LiNO<sub>3</sub>, 0.1 M ADA pH 6.5, 32.8% PEG 600</td><td align="left" valign="bottom">0.1 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 0.1 M HEPES pH 7.25, 30.8% PEG 600</td><td align="left" valign="bottom">0.1 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 0.1 M HEPES pH 7.1, 33.8% PEG 600</td><td align="left" valign="bottom">0.1 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 0.1 M ADA pH 6.3, 34.8% PEG 600</td><td align="left" valign="bottom">0.2 M NaCl, 0.1 M sodium cacodylate pH 5.2, 34% PEG 600</td><td align="left" valign="bottom">0.1 M calcium acetate, 0.1 M sodium acetate pH 5.0, 40% PEG 600</td><td align="left" valign="bottom">0.1 M NH<sub>4</sub>SO<sub>4</sub>, 0.1 M HEPES pH 7.25, 33% PEG 600</td></tr><tr><td align="left" valign="bottom"><bold>Data collection</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Space group</td><td align="left" valign="bottom">C121</td><td align="left" valign="bottom">C121</td><td align="left" valign="bottom">C121</td><td align="left" valign="bottom">P1</td><td align="left" valign="bottom">C121</td><td align="left" valign="bottom">P1</td><td align="left" valign="bottom">C121</td></tr><tr><td align="left" valign="bottom">Cell dimensions</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><italic>a</italic>, <italic>b</italic>, <italic>c</italic> (Å)</td><td align="left" valign="bottom">141.17, 50.87, 110.79</td><td align="left" valign="bottom">140.71, 50.14, 110.28</td><td align="left" valign="bottom">145.7, 51.83, <break/>114.95</td><td align="left" valign="bottom">50.91, 75.07, 111.43</td><td align="left" valign="bottom">140.64, 49.85, 109.83</td><td align="left" valign="bottom">49.70, 74.32, 107.43</td><td align="left" valign="bottom">140.18, 50.12, 110.73</td></tr><tr><td align="left" valign="bottom">α,β,γ (Å)</td><td align="left" valign="bottom">90, 92.69, 90</td><td align="left" valign="bottom">90, 93.45, 90</td><td align="left" valign="bottom">90, 92.67, 90</td><td align="left" valign="bottom">92.03, 90.33, 109.20</td><td align="left" valign="bottom">90, 93.75, 90</td><td align="left" valign="bottom">93.56, 89.71, 109.92</td><td align="left" valign="bottom">90, 92.79, 90</td></tr><tr><td align="left" valign="bottom">Resolution (Å)</td><td align="left" valign="bottom">70.5–3.22 (3.42–3.22)</td><td align="left" valign="bottom">70.2–3.36 (3.62–3.36)</td><td align="left" valign="bottom">114.8–3.75 (4.37–3.75)</td><td align="left" valign="bottom">70.8–3.13 (3.41–3.13)</td><td align="left" valign="bottom">70.2–2.85 (3.16–2.85)</td><td align="left" valign="bottom">107.2–2.32 (2.67–2.32)</td><td align="left" valign="bottom">70.50–3.22 (3.42–3.22)</td></tr><tr><td align="left" valign="bottom">Ellipsoidal Resolution Limit (best/worst)<xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="left" valign="bottom">3.22/4.33</td><td align="left" valign="bottom">3.36/5.1</td><td align="left" valign="bottom">3.75/6.34</td><td align="left" valign="bottom">3.13/4.50</td><td align="left" valign="bottom">2.85/3.72</td><td align="left" valign="bottom">2.32/3.55</td><td align="left" valign="bottom">3.22/4.33</td></tr><tr><td align="left" valign="bottom">% Spherical Data Completeness<xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="left" valign="bottom">69.0 (20.9)</td><td align="left" valign="bottom">54.5 (13.6)</td><td align="left" valign="bottom">44.0 (10.1)</td><td align="left" valign="bottom">52.0 (11.1)</td><td align="left" valign="bottom">62.0 (12.0)</td><td align="left" valign="bottom">41.9 (6.0)</td><td align="left" valign="bottom">69.0 (20.9)</td></tr><tr><td align="left" valign="bottom">% Ellipsoidal Data Completeness<xref ref-type="table-fn" rid="table1fn1">*</xref></td><td align="left" valign="bottom">88.6 (80.1)</td><td align="left" valign="bottom">84.1 (78.5)</td><td align="left" valign="bottom">82.7 (65.7)</td><td align="left" valign="bottom">82.0 (72.3)</td><td align="left" valign="bottom">87.0 (62.6)</td><td align="left" valign="bottom">80.3 (45.6)</td><td align="left" valign="bottom">88.6 (80.1)</td></tr><tr><td align="left" valign="bottom"><italic>R</italic><sub>merge</sub><sup><xref ref-type="table-fn" rid="table1fn1">*</xref></sup></td><td align="left" valign="bottom">0.152 (0.656)</td><td align="left" valign="bottom">0.349 (1.053)</td><td align="left" valign="bottom">0.365 (0.752)</td><td align="left" valign="bottom">0.123 (0.697)</td><td align="left" valign="bottom">0.118 (1.85)</td><td align="left" valign="bottom">0.089 (0.4)</td><td align="left" valign="bottom">0.152 (0.656)</td></tr><tr><td align="left" valign="bottom"><italic>R</italic><sub><italic>meas</italic></sub><sup><xref ref-type="table-fn" rid="table1fn1">*</xref></sup></td><td align="left" valign="bottom">0.166 (0.707)</td><td align="left" valign="bottom">0.384 (1.15)</td><td align="left" valign="bottom">0.396 (0.817)</td><td align="left" valign="bottom">0.144 (0.814)</td><td align="left" valign="bottom">0.129 (1.99)</td><td align="left" valign="bottom">0.104 (0.465)</td><td align="left" valign="bottom">0.166 (0.707)</td></tr><tr><td align="left" valign="bottom">CC<sub>1/2</sub></td><td align="left" valign="bottom">0.967 (0.861)</td><td align="left" valign="bottom">0.779 (0.610)</td><td align="left" valign="bottom">0.992 (0.862)</td><td align="left" valign="bottom">0.939 (0.629)</td><td align="left" valign="bottom">0.994 (0.366)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">0.967 (0.861)</td></tr><tr><td align="left" valign="bottom">Mn <italic>I</italic> / σ<italic>I</italic><sup><xref ref-type="table-fn" rid="table1fn1">*</xref></sup></td><td align="left" valign="bottom">10.4 (2.7)</td><td align="left" valign="bottom">4.0 (1.8)</td><td align="left" valign="bottom">7.4 (2.3)</td><td align="left" valign="bottom">7.7 (1.5)</td><td align="left" valign="bottom">9.5 (1.2)</td><td align="left" valign="bottom">6.5 (2.8)</td><td align="left" valign="bottom">10.4 (2.7)</td></tr><tr><td align="left" valign="bottom">Multiplicity<sup><xref ref-type="table-fn" rid="table1fn1">*</xref></sup></td><td align="left" valign="bottom">6.6 (7.1)</td><td align="left" valign="bottom">5.9 (6.2)</td><td align="left" valign="bottom">6.7 (6.6)</td><td align="left" valign="bottom">3.7 (3.8)</td><td align="left" valign="bottom">6.4 (7.1)</td><td align="left" valign="bottom">3.8 (3.8)</td><td align="left" valign="bottom">6.6 (7.1)</td></tr><tr><td align="left" valign="bottom"><bold>Refinement</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Resolution (Å)</td><td align="left" valign="bottom">55.3–3.22</td><td align="left" valign="bottom">55.0–3.36</td><td align="left" valign="bottom">60.2–3.91</td><td align="left" valign="bottom">32.9–3.13</td><td align="left" valign="bottom">35.2–2.85</td><td align="left" valign="bottom">35.5–2.32</td><td align="left" valign="bottom">55.3–3.91</td></tr><tr><td align="left" valign="bottom">No. reflections</td><td align="left" valign="bottom">8,025</td><td align="left" valign="bottom">6,097</td><td align="left" valign="bottom">3,347</td><td align="left" valign="bottom">14,194</td><td align="left" valign="bottom">11,149</td><td align="left" valign="bottom">26,026</td><td align="left" valign="bottom">5,040</td></tr><tr><td align="left" valign="bottom"><italic>R</italic><sub>work</sub> / <italic>R</italic><sub>free</sub></td><td align="left" valign="bottom">29.4 / 33.4</td><td align="left" valign="bottom">29.0/31.4</td><td align="left" valign="bottom">34.2/34.4</td><td align="left" valign="bottom">30.0/33.1</td><td align="left" valign="bottom">30.7/32.7</td><td align="left" valign="bottom">25.1/29.5</td><td align="left" valign="bottom">33.0/36.7</td></tr><tr><td align="left" valign="bottom">Ramachandran Favored</td><td align="left" valign="bottom">89.4</td><td align="left" valign="bottom">89.6</td><td align="left" valign="bottom">90.9</td><td align="left" valign="bottom">89.1</td><td align="left" valign="bottom">91.0</td><td align="left" valign="bottom">92.9</td><td align="left" valign="bottom">88.7</td></tr><tr><td align="left" valign="bottom">Ramachandran Outliers</td><td align="left" valign="bottom">1.9</td><td align="left" valign="bottom">1.9</td><td align="left" valign="bottom">2.4</td><td align="left" valign="bottom">2.6</td><td align="left" valign="bottom">1.9</td><td align="left" valign="bottom">1.5</td><td align="left" valign="bottom">2.7</td></tr><tr><td align="left" valign="bottom">Clashscore</td><td align="left" valign="bottom">11.8</td><td align="left" valign="bottom">13.6</td><td align="left" valign="bottom">8.4</td><td align="left" valign="bottom">16.8</td><td align="left" valign="bottom">8.6</td><td align="left" valign="bottom">10.4</td><td align="left" valign="bottom">14.9</td></tr><tr><td align="left" valign="bottom">R.m.s. deviations</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Bond lengths (Å)</td><td align="left" valign="bottom">0.003</td><td align="left" valign="bottom">0.003</td><td align="left" valign="bottom">0.003</td><td align="left" valign="bottom">0.004</td><td align="left" valign="bottom">0.003</td><td align="left" valign="bottom">0.004</td><td align="left" valign="bottom">0.004</td></tr><tr><td align="left" valign="bottom">Bond angles (°)</td><td align="left" valign="bottom">0.70</td><td align="left" valign="bottom">0.68</td><td align="left" valign="bottom">0.60</td><td align="left" valign="bottom">0.82</td><td align="left" valign="bottom">.65</td><td align="left" valign="bottom">0.70</td><td align="left" valign="bottom">0.67</td></tr><tr><td align="left" valign="bottom">Coordinates in Protein Databank</td><td align="left" valign="bottom">7SSU</td><td align="left" valign="bottom">7SV9</td><td align="left" valign="bottom">7SVX</td><td align="left" valign="bottom">7 MGX</td><td align="left" valign="bottom">7MH6</td><td align="left" valign="bottom">7SZT</td><td align="left" valign="bottom">7 T00</td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><label>*</label><p>Where applicable, values reported are for anisotropically truncated data performed using the Staraniso webserver (Global Phasing). See <italic>Methods</italic> for details.</p></fn></table-wrap-foot></table-wrap><p>The structure of the EmrE<sub>3</sub>/L10 complex (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) shows an antiparallel EmrE<sub>3</sub> dimer bound to two monobodies in slightly different orientations via the loop one residues. The crystal packing is similar to Gdx-Clo, with the majority of contacts mediated by monobody. The introduced E25N sidechain of EmrE<sub>3</sub> is within hydrogen bonding distance of a tyrosine sidechain contributed by the monobody, and W31I contributes to a hydrophobic patch of the transporter/monobody interface. These interactions are homologous to those observed for the Gdx-Clo/L10 complex. The third mutant sidechain of EmrE<sub>3</sub>, V34M, does not interact with monobody in this structure, and therefore might not be necessary for monobody binding to EmrE<sub>3</sub>.</p><p>In our EmrE<sub>3</sub> model, the positions of the helices agree with those observed in existing low-resolution electron microscopy maps of EmrE (<xref ref-type="bibr" rid="bib54">Ubarretxena-Belandia et al., 2003</xref>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). Compared with a previous MD model based on that EM data (<xref ref-type="bibr" rid="bib55">Vermaas et al., 2018</xref>), our current EmrE<sub>3</sub> crystal structure has a C<sub>α</sub> RMSD of 2.5 Å, with close correspondence of residues that contribute to the substrate-binding pocket (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>). Although EmrE<sub>3</sub> has high structural similarity to Gdx-Clo (C<sub>α</sub> RMSD 1.2 Å for the dimer), the structures display clear differences in subunit packing. Relative to Gdx-Clo, in EmrE<sub>3</sub> helices 1–3 of the A subunit, which line the binding pocket, are each displaced by 1.5–2.5 Å (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>). These shifts slightly expand the aqueous cavity of EmrE<sub>3</sub> relative to Gdx-Clo.</p><p>As in Gdx-Clo, the two monomers adopt different structures. Monomers A and B differ from each other in the relative orientation of their two lobes (residues 1–66 and 67–103) about a fulcrum at the conserved GVG motif in helix 3 (residues 65–67; <xref ref-type="fig" rid="fig2">Figure 2B</xref>). The angle of the bend in TM3 at the GVG sequence is somewhat more pronounced in monomer A (17°) than in monomer B (9°). The observed architecture is in accord with the proposed conformational swap of two structurally distinct monomers (<xref ref-type="bibr" rid="bib33">Morrison et al., 2011</xref>).</p><p>The residue S64 is positioned immediately before the GVG fulcrum, at the boundary of lobe 1 and lobe 2 for each EmrE<sub>3</sub> subunit. In the crystal structure, the S64 sidechains contributed by the two subunits are within hydrogen bonding distance and geometry, with strong contiguous electron density between them (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Due to the antiparallel architecture, the outward- and inward-facing conformations of the transporter are expected to be structurally identical and related by twofold symmetry about an axis parallel to the plane of the membrane (<xref ref-type="bibr" rid="bib16">Fleishman et al., 2006</xref>). Thus, the S64 interaction should be preserved when the transporter is open to the opposite side of the membrane; we therefore imagine that the S64 sidechains remain hydrogen bonded to each other during the entire transport cycle, forming the pivot point around which the conformational change occurs.</p><p>In the absence of ligand, EmrE<sub>3</sub> possesses a deep, spacious aqueous pocket that is accessible from one side of the membrane (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The E14 sidechains contributed by both subunits define the edges of this binding pocket. E14 is invariant in the SMR family and essential for binding both substrate and protons (<xref ref-type="bibr" rid="bib61">Yerushalmi and Schuldiner, 2000</xref>). The present crystals formed at pH 5.2, at which both E14 sidechains are expected to be protonated (<xref ref-type="bibr" rid="bib28">Li et al., 2021</xref>; <xref ref-type="bibr" rid="bib34">Morrison et al., 2015</xref>). There is a small, spherical density in the vestibule between W63<sub>B</sub> and E14<sub>A</sub> that is consistent with a water molecule, although no other ordered water molecules are visible at this resolution (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). The cross-subunit interaction between Y60<sub>B</sub> and E14<sub>A</sub> proposed by Vermaas et al. is observed (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). A conserved hydrogen bond acceptor, T18<sub>A</sub>, is located one helical turn down from E14<sub>A</sub> and engaged in an intrasubunit interaction with Y40<sub>A</sub> (<xref ref-type="fig" rid="fig2">Figure 2D</xref>).</p><p>As in Gdx-Clo, the TM2 helices splay apart on the open side of the transporter, defining a portal from the membrane to the substrate binding site that is lined with hydrophobic sidechains (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). This portal may play a dual role, rearranging to allow alkyl substituents to reside in the membrane during the transport cycle, as well as providing the opportunity for hydrophobic drugs to diffuse laterally from the membrane into the substrate binding site. Aromatic residues contributed by loop 1<sub>A</sub>, including the highly conserved F27 sidechain, are wedged between the hydrophobic sidechains lining helices 2<sub>A</sub> and 2<sub>B</sub>, sealing the closed side of the transporter (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p></sec><sec id="s2-3"><title>Structures of substrate-bound EmrE<sub>3</sub></title><p>To understand how different substrates interact with EmrE, we screened a variety of transported compounds in crystallization trials. We were able to obtain diffracting crystals in the presence of five structurally diverse compounds transported by EmrE: monovalent planar aromatic harmane (3.8 Å), divalent planar aromatic methyl viologen (3.1 Å), quaternary phosphoniums tetraphenylphosphonium (TPP<sup>+</sup>; 3.4 Å) and methyltriphenylphosphonium (MeTPP<sup>+</sup>; 3.2 Å), and quaternary ammonium benzyltrimethylammonium (3.9 Å) (<xref ref-type="table" rid="table1">Table 1</xref>). We were unable to generate crystals that diffracted to high resolution in the presence of metformin, benzalkonium, cetyltrimethylammonium, or octylguanidinium. Phases of the EmrE<sub>3</sub>/substrate/L10 monobody complexes were determined using molecular replacement with the pH 5.2 structure as a search model. Although the crystallization conditions varied for each substrate, the TPP<sup>+</sup>-, MeTPP<sup>+</sup>-, benzyltrimethylammonium-, and harmane-bound proteins crystallized in the same unit cell as proton-bound EmrE<sub>3</sub>, with one copy of the EmrE<sub>3</sub>/L10 complex in the asymmetric unit. The methyl viologen-bound protein crystallized in P1 with two pseudosymmetric copies of the EmrE3/L10 complex in the asymmetric unit, organized in the same relative orientation as individual complexes in the C121 crystal form.</p><p>Since Gdx-Clo and EmrE<sub>3</sub> were both accommodated in this crystal lattice despite differences in the tilt and packing of helices 1, 2, and 3, we expect that small 1–2 Å substrate-dependent movements in the backbone of EmrE<sub>3</sub> would also be tolerated within this crystal lattice. However, in all four substrate-bound structures, the transmembrane helices and loops 1 and 2 conform almost perfectly to the pH 5.2 structure (C<sub>α</sub> RMSD = 0.5–0.65 Å), suggesting that the observed backbone conformation is the lowest energy state for both the substrate- and proton-bound transporter. Loop three is poorly ordered and adopts a different conformation in each of the structures in which it is resolved well enough to model.</p><p>For all substrate-bound structures, the maps show positive densities between the substrate-binding E14 residues, including a four-lobed density for TPP<sup>+</sup>, a three-lobed density for MeTPP<sup>+</sup>, and oblong densities for the harmane and the methyl viologen structures. We modeled the corresponding substrates into each of these densities (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). All five drugs are bound at the bottom of the aqueous cavity, in overlapping positions at the midpoint of the membrane. In the two copies of the methyl viologen-bound transporter, the drug is bound in different (but overlapping) positions (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). For all substrates, the center of mass is poised midway between the E14 residues. To different extents, the substrates also interact with the protein’s aromatic residues via ring stacking, especially Y60 and W63.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Substrate binding to EmrE<sub>3</sub>.</title><p>(<bold>A</bold>) Structures are shown in ribbon representation, with sidechains E14, W63, and Y60 shown as sticks. All panels are zoomed and oriented the same. 2mF<sub>o</sub>-DF<sub>c</sub> maps (carved 2 Å around each substrate) are shown as cyan mesh. Maps are contoured at 1σ for harmane and 1.2σ for MeTPP<sup>+</sup>, TPP<sup>+</sup>, methylviologen, and benzyltrimethylammonium (BM<sub>3</sub>A<sup>+</sup>). (<bold>B</bold>) Top row: Substrate structures and 2mF<sub>o</sub>-DF<sub>c</sub> maps from the panels in A, individually rotated to view each substrate. Bottom row: mF<sub>o</sub>-DF<sub>c</sub> substrate omit maps shown as green mesh. Omit maps are contoured at 1.8σ for harmane and 2σ for MeTPP<sup>+</sup>, TPP<sup>+</sup>, methylviologen, and BM<sub>3</sub>A<sup>+</sup>. (<bold>C</bold>) Comparison of E14 and W63 positions in each substrate-bound structure. Individual panels show substrate, E14, and W63 from indicated structure in color aligned with the other four structures, which are rendered in light gray.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Electron density maps of methyl viologen in different EmrE<sub>3</sub> protomers in the asymmetric unit.</title><p>Yellow stick representations (top panels) show the modeled position of methyl viologen in each protomer, with the final refined maps shown as mesh. White stick representations show the methyl viologen position swapped between the two protomers. Maps show a subsequent re-refinement with the substrates in the swapped positions. For all panels, 2F<sub>o</sub>-F<sub>c</sub> density (cyan) contoured at 1.2σ and F<sub>o</sub>-F<sub>c</sub> density (green or red) contoured at 2.5 σ.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Electron density maps for W63<sub>A</sub> modeled in different positions.</title><p>Top panels: 2F<sub>o</sub>-F<sub>c</sub> density contoured at 1.8σ and F<sub>o</sub>-F<sub>c</sub> density contoured at 3 σ. Bottom panels: 2F<sub>o</sub>-F<sub>c</sub> density contoured at 1.2 σ and F<sub>o</sub>-F<sub>c</sub> density contoured at 2.5 σ.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Electron density maps for E14<sub>B</sub> modeled in different positions.</title><p>Top panels: 2F<sub>o</sub>-F<sub>c</sub> density contoured at 1.8σ and F<sub>o</sub>-F<sub>c</sub> density contoured at 3 σ. Bottom panels: 2F<sub>o</sub>-F<sub>c</sub> density contoured at 1.2 σ and F<sub>o</sub>-F<sub>c</sub> density contoured at 2.5 σ.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig3-figsupp3-v2.tif"/></fig></fig-group><p>Comparison of these structures permitted evaluation of the specific orientations of the sidechains that line the substrate binding site (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). The harmane- and benzyltrimethylammonium-bound structure was excluded from this analysis because, at 3.8–3.9 Å resolution, we were not as confident about interpreting subtle changes in sidechain orientation. For the other substrates (methyl viologen, TPP<sup>+</sup>, and MeTPP<sup>+</sup>), this comparison showed that binding site sidechains, especially E14 and W63, adopt different rotamers, thus accommodating the differently sized substrates. For example, the carboxylate of E14<sub>B</sub> is displaced by 2.5 Å when the bulky quaternary phosphonium TPP<sup>+</sup> is bound, compared to its position when the planar methyl viologen occupies the binding site. Likewise, the position of the W63<sub>A</sub> indole ring rotates over approximately 80° depending on the substrate that occupies the binding site. To validate these observations, we performed refinements with models in which the position of the W63<sub>A</sub> or E14<sub>B</sub> sidechain was adjusted to match its position in the presence of a dissimilar substrate; the resulting difference density demonstrates that these substrate-dependent changes in sidechain rotamer are not due to model bias during the refinement (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>, <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). Thus, these structures provide a first suggestion of how rotameric movements of EmrE’s charged and aromatic sidechains can change the dimensions of the binding pocket and interact favorably with diverse substrates.</p></sec><sec id="s2-4"><title>Structure of Gdx-Clo at pH 5 and comparison to the substrate binding site of EmrE</title><p>The overall fold and many of the binding site sidechains are shared between EmrE and Gdx-Clo, yet the two proteins have markedly different substrate selectivity profiles. We therefore sought to analyze how molecular interactions among binding site residues might explain the different substrate selectivity for EmrE and Gdx-Clo. Previous structures of Gdx-Clo were solved at pH ≥7.5 in complex with substituted guanidinyl compounds (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>). In order to compare the substrate-binding sites of Gdx-Clo and EmrE<sub>3</sub> in equivalent states, we solved a new structure of Gdx-Clo at pH 5.0, which is close to the value for the present low pH EmrE<sub>3</sub> structure, pH 5.2 (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Both transporters are likely proton-bound at this pH, minimizing differences in sidechain positioning that might stem from interactions with bound substrate. This new structure of proton-bound Gdx-Clo, which is resolved to 2.3 Å, is highly similar to the structure of substrate-bound Gdx-Clo (PDB: 6WK8), with only a local change in the rotamer of the substrate-binding glutamate E13<sub>B</sub> (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>).</p><p>A comparison of the low-pH EmrE<sub>3</sub> and Gdx-Clo structures reveals conspicuous differences in the hydrogen bond network within the binding cavity (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>), despite the conservation of many key residues. In Gdx-Clo, Ser42 participates in the stack of alternating hydrogen bond donors and acceptors (W16<sub>Clo</sub>/E13<sub>Clo</sub>/S42<sub>Clo</sub>/W62<sub>Clo</sub>) that fixes the position of the central Glu, E13. Although the analogous serine (S43<sub>EmrE</sub>) is present in EmrE, it is not playing an analogous role. A 1.5 Å displacement in helix two has distanced this Ser from the other sidechains in the binding pocket, beyond hydrogen bonding distance with W63<sub>EmrE</sub>. Instead, S43<sub>EmrE</sub> is rotated away from the aqueous cavity and the central E14<sub>EmrE</sub> residues. Despite strict conservation of this serine among the Gdx subtype, mutation to alanine occurs in ~30% of homodimeric Qacs (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). In lieu of an interaction with S43<sub>EmrE</sub>, both W63<sub>EmrE</sub> sidechains in EmrE adopt different rotamers compared to their counterparts in Gdx-Clo. W63<sub>A, EmrE</sub> is oriented so that its indole NH is within H-bonding distance of Y60<sub>B, EmrE</sub>, although the angle between the H-bond donor and acceptor is ~30° off normal.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Structure and sequence conservation of substrate binding site residues in Qac and Gdx subtypes.</title><p>(<bold>A</bold>) Substrate-binding site in EmrE, with subunit B in orange and subunit A in blue. (<bold>B</bold>) Substrate-binding site in Gdx-Clo, with subunit B in wheat and subunit A in pale cyan (PDB: 6WK8). For panels A and B, the proteins are shown in the same orientation. Note that residue numbering is offset by one in Gdx-Clo. Potential hydrogen bonds are shown as dashed lines. (<bold>C</bold>) Amino acid conservation analysis for the Qac and Gdx subtypes overlaid on exemplar sequences of EmrE and Gdx-Clo, respectively. Analysis was performed using ConSurf (<xref ref-type="bibr" rid="bib3">Ashkenazy et al., 2016</xref>; <xref ref-type="bibr" rid="bib8">Berezin et al., 2004</xref>). Residues that contribute to the binding pocket and that are conserved between the Qac and Gdx subtypes are indicated with an astericks. Residues that contribute to the binding pocket and that differ between the Qac and Gdx subtypes are indicated with a circle. The monobody binding loop 1 is indicated by the sold line. Alignments of representative sequences are shown in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Gdx-Clo and EmrE substrate binding sites.</title><p>(<bold>A</bold>) 2F<sub>o</sub>-F<sub>c</sub> map shown around selected residues in the Gdx-Clo substrate binding site (pH 5.2) contoured at 1.5 σ. (<bold>B</bold>) Alignment of Gdx-Clo structures. The present pH 5.2 structure is shown in wheat and cyan with putative H-bond interactions shown as yellow dashed lines. The structure with phenylGdm<sup>+</sup> bound is shown in light gray with putative H-bonds between the substrate and the E13 residues shown as gray dashed lines.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Sequence alignments of five representative Gdx proteins (from top to bottom: <italic>Clostridiales</italic> bacterium oral taxon 876, <italic>E</italic>. <italic>coli</italic>, <italic>Micromonospora</italic>, <italic>Streptomyces tsukubensis</italic>, and <italic>Leifsonia aquatica)</italic> and five representative Qac proteins (from top to bottom: <italic>E. coli</italic>, <italic>Klebsiella pneumoniae, Pseudomonas aeruginosa, Mycobacterium bovis, and Bordetella avium</italic>).</title><p>Sequence numbering corresponds to EmrE. Sequences are colored according to sequence conservation (shades of blue). Residues that contribute to the binding pocket and that are conserved between the Qac and Gdx subtypes are highlighted in orange. Residues that contribute to the binding pocket and that differ in the Qac and Gdx subtypes are highlighted in black.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig4-figsupp2-v2.tif"/></fig></fig-group><p>The fourth residue from Gdx-Clo’s H-bond stack, W16<sub>Clo</sub>, is universally conserved in Gdx proteins, but replaced with a glycine or alanine in the Qacs (G17 in EmrE). There is no equivalent H-bond donor to the central Glu in EmrE. Instead, the sidechain Y40<sub>EmrE</sub> occupies this space, but interacts with T18<sub>EmrE</sub> located one helical turn away from E14<sub>EmrE</sub>. This pair, Y40<sub>EmrE</sub> and T18<sub>EmrE</sub>, are highly conserved among the Qacs, and variable and typically hydrophobic in Gdx proteins. In Gdx-Clo, the corresponding positions are M39<sub>Clo</sub> and A17<sub>Clo</sub>. This trio of correlated positions (W16<sub>Clo</sub>/G17<sub>EmrE</sub>, A17<sub>Clo</sub>/T18<sub>EmrE</sub>, and M39<sub>Clo</sub>/Y40<sub>EmrE</sub>) in the substrate-binding site are among the main features that differentiate the Gdx and Qac subtypes in sequence alignments (<xref ref-type="fig" rid="fig4">Figure 4C</xref>).</p><p>Y60<sub>A, EmrE</sub> also adopts a different orientation in EmrE relative to the position of the analogous Tyr, Y59<sub>Clo</sub> in Gdx-Clo. Rather than extending out of the binding pocket toward the exterior solution, as it does in Gdx-Clo, Y60<sub>A, EmrE</sub> is pointed down toward the S64<sub>EmrE</sub> diad. This rotamer would not be possible in Gdx-Clo, since this space is occupied by K101<sub>Clo</sub> instead, which extends from the C-terminal end of helix 4 and points down into the substrate-binding pocket toward the glutamates. K101<sub>Clo</sub> is completely conserved in the Gdx subtype.</p><p>The overall picture that emerges from this comparison of the Gdx-Clo and EmrE structures is that the two proteins share many binding site residues but differ in the relative organization of these residues. In Gdx-Clo, E13<sub>Clo</sub>, S42<sub>Clo</sub>, Y59<sub>Clo</sub>, and W62<sub>Clo</sub> are constrained in a highly organized H-bond network. In EmrE, residues peripheral to the binding site have encroached on these positions, disrupting the network and reducing the number of protein hydrogen bond partners for each of these conserved sidechains.</p></sec><sec id="s2-5"><title>EmrE is tolerant of mutations that eliminate hydrogen bonding in the binding pocket</title><p>Based on structural comparison of the Gdx-Clo and EmrE-binding pockets, we hypothesize that even for conserved residues in the binding pocket, the importance of hydrogen bonding is diminished in EmrE relative to Gdx-Clo. To probe this, we performed a head-to-head comparison of SSM currents mediated by EmrE and Gdx-Clo proteins with mutations at three conserved positions adjacent to the functionally essential central Glu: Y59F<sub>Clo</sub>/Y60F<sub>EmrE</sub>, S42A<sub>Clo</sub>/S43A<sub>EmrE</sub>, and W62F<sub>Clo</sub>/W63F<sub>EmrE</sub> (<xref ref-type="fig" rid="fig5">Figure 5</xref>, <xref ref-type="table" rid="table2">Table 2</xref>). All six mutant transporters were expressed at near-WT levels and monodisperse by size exclusion chromatography. For EmrE mutants, we tested transport of 2 mM PheGdm<sup>+</sup> or 2 mM TPA<sup>+</sup>, and for Gdx-Clo, we tested transport of its native substrate, 1 mM Gdm<sup>+</sup>. For all experiments, substrate concentration was ~4 fold higher than the transport K<sub>m</sub>.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Representative SSM electrophysiology recordings for EmrE<sub>3</sub> and Gdx-Clo mutants.</title><p>For EmrE<sub>3</sub>, PheGdm<sup>+</sup> and TPA<sup>+</sup> traces are from the same sensor and shown on the same scale. Vertical box edges are 3 nA for PheGdm<sup>+</sup> traces, and 6 nA for TPA<sup>+</sup> traces. For Gdx-Clo, vertical box edges are 7 nA. Horizontal box edges are 2 s for all traces. Dashed line represents the zero-current level. Traces are representative of currents from three independently prepared sensors and two independent biochemical preparations. Peak current values for all replicates are reported in <xref ref-type="table" rid="table2">Table 2</xref>. Note that because there is some sensor-to-sensor variation in liposome fusion, comparisons of current amplitude among the mutants are qualitative.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>SSM electrophysiology traces for EmrE<sub>3</sub> mutants and Gdx-Clo mutants.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-76766-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig5-v2.tif"/></fig><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>SSM electrophysiology peak currents (nA) for EmrE<sub>3</sub> and Gdx-Clo mutants summarized by experimental replicate.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="7" valign="top">EmrE<sub>3</sub></th></tr></thead><tbody><tr><td align="left" valign="top"/><td align="left" colspan="2" valign="top">Prep 1/Sensor 1</td><td align="left" colspan="2" valign="top">Prep 1/Sensor 2</td><td align="left" colspan="2" valign="top">Prep 2/Sensor 1</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">TPA<sup>+</sup></td><td align="left" valign="top">PheGdm<sup>+</sup></td><td align="left" valign="top">TPA<sup>+</sup></td><td align="left" valign="top">PheGdm<sup>+</sup></td><td align="left" valign="top">TPA<sup>+</sup></td><td align="left" valign="top">PheGdm<sup>+</sup></td></tr><tr><td align="left" valign="top">No protein</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td><td align="char" char="." valign="top">0</td></tr><tr><td align="left" valign="top">WT</td><td align="char" char="." valign="top">–4.8</td><td align="char" char="." valign="top">–1.4</td><td align="char" char="." valign="top">–4.1</td><td align="char" char="." valign="top">–1.2</td><td align="char" char="." valign="top">–3.9</td><td align="char" char="." valign="top">–1.0</td></tr><tr><td align="left" valign="top">Y60F</td><td align="char" char="." valign="top">–0.14</td><td align="char" char="." valign="top">–0.03</td><td align="char" char="." valign="top">–0.05</td><td align="char" char="." valign="top">–0.07</td><td align="char" char="." valign="top">–0.04</td><td align="char" char="." valign="top">–0.05</td></tr><tr><td align="left" valign="top">S43A</td><td align="char" char="." valign="top">–3.7</td><td align="char" char="." valign="top">–1.6</td><td align="char" char="." valign="top">–3.9</td><td align="char" char="." valign="top">–1.3</td><td align="char" char="." valign="top">–3.2</td><td align="char" char="." valign="top">–1.2</td></tr><tr><td align="left" valign="top">W63F</td><td align="char" char="." valign="top">–5.4</td><td align="char" char="." valign="top">–2.0</td><td align="char" char="." valign="top">–4.6</td><td align="char" char="." valign="top">–1.5</td><td align="char" char="." valign="top">–4.0</td><td align="char" char="." valign="top">–1.0</td></tr><tr><td align="left" colspan="7" valign="top"><bold>Gdx-Clo</bold></td></tr><tr><td align="left" valign="top"/><td align="left" colspan="2" valign="top">Prep 1/Sensor 1 (Gdm<sup>+</sup>)</td><td align="left" colspan="2" valign="top">Prep 1/Sensor 2 (Gdm<sup>+</sup>)</td><td align="left" colspan="2" valign="top">Prep 2/Sensor 1 (Gdm<sup>+</sup>)</td></tr><tr><td align="left" valign="top">No protein</td><td align="char" char="." colspan="2" valign="top">0</td><td align="char" char="." colspan="2" valign="top">0</td><td align="char" char="." colspan="2" valign="top">0</td></tr><tr><td align="left" valign="top">WT</td><td align="char" char="." colspan="2" valign="top">–6.3</td><td align="char" char="." colspan="2" valign="top">–6.7</td><td align="char" char="." colspan="2" valign="top">–6.3</td></tr><tr><td align="left" valign="top">Y60F</td><td align="char" char="." colspan="2" valign="top">0.04</td><td align="char" char="." colspan="2" valign="top">0.007</td><td align="char" char="." colspan="2" valign="top">0.6</td></tr><tr><td align="left" valign="top">S43A</td><td align="char" char="." colspan="2" valign="top">–0.15</td><td align="char" char="." colspan="2" valign="top">–0.15</td><td align="char" char="." colspan="2" valign="top">–0.15</td></tr><tr><td align="left" valign="top">W63F</td><td align="char" char="." colspan="2" valign="top">–0.60</td><td align="char" char="." colspan="2" valign="top">–0.33</td><td align="char" char="." colspan="2" valign="top">–0.30</td></tr></tbody></table></table-wrap><p>In line with its proposed role as a conformational switch (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>; <xref ref-type="bibr" rid="bib55">Vermaas et al., 2018</xref>), no currents were observed when the binding site Tyr (Y59<sub>Clo</sub>/Y60<sub>EmrE</sub>) was mutated in either protein. This result recapitulates results from prior radioactive uptake studies of both mutants (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>; <xref ref-type="bibr" rid="bib43">Rotem et al., 2006</xref>). It also establishes a dead-transporter control for our SSM electrophysiology assays. We likewise find that Gdx-Clo does not tolerate perturbation to its hydrogen bond stack. Although neither S42A<sub>Clo</sub> nor W62F<sub>Clo</sub> directly bind Gdm<sup>+</sup>, both mutations eliminate Gdm<sup>+</sup> currents in SSM electrophysiology assays. In contrast, EmrE<sub>3</sub> was relatively indifferent to the S43A<sub>EmrE</sub> and W63F<sub>EmrE</sub> mutations, with robust currents evoked by both TPA<sup>+</sup> and PheGdm<sup>+</sup>.</p><p>This result for S43<sub>EmrE</sub> reinforces the structural suggestion that the serine’s functional role in the Gdx transporters is not conserved in the Qac subtype, and is also in agreement with prior transport and resistance assays that showed that S43<sub>EmrE</sub> modulates substrate specificity in EmrE, but is not required for transport function (<xref ref-type="bibr" rid="bib9">Brill et al., 2015</xref>; <xref ref-type="bibr" rid="bib59">Wu et al., 2019</xref>). The observation of robust transport by W63F<sub>EmrE</sub> is more surprising, since this mutant has been shown to reduce TPP<sup>+</sup> binding by two orders of magnitude, and abolish methyl viologen transport and bacterial resistance to TPP<sup>+</sup>, methyl viologen, and acriflavine (<xref ref-type="bibr" rid="bib14">Elbaz et al., 2005</xref>). Other mutations to W63 (to C, A, or V) also fail to provide resistance against polyaromatic substrates (<xref ref-type="bibr" rid="bib2">Amadi et al., 2010</xref>; <xref ref-type="bibr" rid="bib14">Elbaz et al., 2005</xref>; <xref ref-type="bibr" rid="bib59">Wu et al., 2019</xref>). To our knowledge, the consequences of W63<sub>EmrE</sub> mutation have not been previously investigated for non-aromatic substrates in biochemical assays. Our SSM electrophysiology results suggest that maintaining a hydrogen bond donor at W63<sub>EmrE</sub> is not essential, and that the conservation of W63<sub>EmrE</sub> is not a mechanistic requirement for EmrE transport, but is instead a determinant of aromatic substrate specificity. In agreement with this interpretation, bacterial growth assays have shown that W63<sub>EmrE</sub> mutants retain resistance to non-aromatic biocides (<xref ref-type="bibr" rid="bib45">Saleh et al., 2018</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this work, we describe substrate- and proton-bound crystal structures of the <italic>E. coli</italic> SMR transporter EmrE, which is wildtype except for three functionally neutral mutations that enable monobody binding, and thus, crystallization. Functional assays show that the engineered protein, EmrE<sub>3</sub> behaves like wildtype, and that the transporter remains functional in the presence of monobody. Below, we discuss the crystallization strategy, we evaluate differences between our crystal structures and a recent NMR-derived model of EmrE (<xref ref-type="bibr" rid="bib48">Shcherbakov et al., 2021</xref>), and discuss the implications of our structures for understanding substrate polyspecificity by EmrE.</p><sec id="s3-1"><title>The application of multipurpose chaperones for crystallization</title><p>The minimal monobody binding interface permitted a crystallization chaperone developed for Gdx-Clo to be repurposed for binding and crystallization of a new target with structural homology, but only 35% sequence identity to the original, streamlining the structural characterization process. Given the similarity of this loop among diverse SMR proteins, we think that this approach would likely facilitate the structural characterization of any target within the SMR family. Such general adapters and chaperones to facilitate structural biology have been described before for various targets (<xref ref-type="bibr" rid="bib12">Dutka et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Koldobskaya et al., 2011</xref>; <xref ref-type="bibr" rid="bib31">McIlwain et al., 2021</xref>; <xref ref-type="bibr" rid="bib36">Mukherjee et al., 2020</xref>). Although identification of a general SMR monobody was not the original intent of the monobody selection, in cases where multiple homologous targets have been identified, variants with identical or near-identical epitopes could be generated, and binders with broad utility could presumably be selected for. Especially in the case of bacterial proteins, in which there are many clinically relevant homologues from many diverse species, such general structural biology approaches hold particular promise to facilitate molecular characterization of membrane protein targets.</p><p>The monobody chaperones mediate most of the crystal contacts, permitting Gdx-Clo and EmrE to crystallize in a nearly identical unit cell, despite some structural differences, including 1–2 Å displacements of helices that contribute to the binding pocket. Although it is a misconception that crystallization chaperones can ‘force’ the transporter into a non-native, high-energy conformation (<xref ref-type="bibr" rid="bib24">Koide, 2009</xref>), it is plausible that the monobody chaperones recognize a less-prevalent conformation, and kinetically trap the transporter in a minority state within the native conformational ensemble. Because these monobodies were not selected against EmrE, but against a different homologue from the SMR family, this is a possibility that should be considered. However, two lines of evidence disfavor the possibility that the monobody-bound state is aberrant. First, we showed that monobody binding has only a minor effect on transport function, and second, our model corresponds closely to the helix density in the EM dataset, which was obtained without exogenous binding proteins (<xref ref-type="bibr" rid="bib54">Ubarretxena-Belandia et al., 2003</xref>). Although local perturbations at the monobody-binding interface of loops 1<sub>A</sub> and 1<sub>B</sub> cannot be ruled out, the position of loop 1<sub>A</sub> is consistent with prior spectroscopic data, which predicted that in the major solution conformation, F27<sub>A</sub> packs against the B subunit with its sidechain oriented toward the substrate-binding site (<xref ref-type="bibr" rid="bib11">Dastvan et al., 2016</xref>). Loop 1<sub>B</sub> is located on the open side of the transporter and does not form any intra-transporter contacts. Therefore, even if monobody does stabilize a less-prevalent conformation of loop 1<sub>B</sub>, this would not change the major interpretations of the present structures.</p></sec><sec id="s3-2"><title>Comparison to the NMR model of EmrE S64V</title><p>An NMR-based model of the ‘slow-exchanging’ EmrE mutant S64V was recently published (<xref ref-type="bibr" rid="bib48">Shcherbakov et al., 2021</xref>). S64V binds substrate with similar affinity as wildtype, but the rate of conformational exchange is about an order of magnitude slower (<xref ref-type="bibr" rid="bib59">Wu et al., 2019</xref>). This model was computed based on chemical shift measurements and distance restraints between the protein backbone and the fluorinated substrate tetrafluorophenyl phosphonium (F-TPP<sup>+</sup>). Although our present crystal structures agree with the NMR model in general aspects, such as the antiparallel topology, there are also notable differences in the global conformation, with an overall RMSD of 2.3 Å for the two models. Relative to other models of EmrE, including the computational models (<xref ref-type="bibr" rid="bib39">Ovchinnikov et al., 2018</xref>; <xref ref-type="bibr" rid="bib55">Vermaas et al., 2018</xref>), the EM α-helical model (<xref ref-type="bibr" rid="bib54">Ubarretxena-Belandia et al., 2003</xref>), and the present crystal structures, in the NMR model the first lobe of the A subunit is shifted down in a direction perpendicular to the membrane with respect to the B subunit (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Note that chain A of the NMR structure is more structurally homologous to chain B of the crystal structure and vice versa. Our designation of chains A and B in the present crystal structure correspond to the A and B chains in previous literature, including SMR family homologue Gdx-Clo (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>), the low-resolution EmrE structures of EmrE (<xref ref-type="bibr" rid="bib10">Chen et al., 2007</xref>; <xref ref-type="bibr" rid="bib16">Fleishman et al., 2006</xref>), and theoretical EmrE models (<xref ref-type="bibr" rid="bib39">Ovchinnikov et al., 2018</xref>; <xref ref-type="bibr" rid="bib55">Vermaas et al., 2018</xref>) This difference in subunit packing is accompanied by subtle differences in the tilts of the helices (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). In the NMR structure, helix 2<sub>A</sub> and 2<sub>B</sub> become more parallel, and the gap between them is narrowed, reducing membrane access to the binding site via the portal.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Comparisons of NMR and crystallography models of EmrE.</title><p>(<bold>A</bold>) Overlay of crystallography (orange/blue), computational (yellow/cyan; <xref ref-type="bibr" rid="bib55">Vermaas et al., 2018</xref>) and NMR (dark red/pale blue; <xref ref-type="bibr" rid="bib48">Shcherbakov et al., 2021</xref>) models, aligned over the B subunit. Y40 sidechain sticks are show as landmarks. (<bold>B</bold>) Side-by-side comparisons of the crystallography and NMR models, with A subunit in blue and B subunit in orange. E14 sidechains shown as landmarks. (<bold>C</bold>) Comparison of Y60<sub>B</sub> hydrogen bonding network in the crystal structure (left) and NMR structure (right). EmrE dimers are shown with TM 1 and 2 of subunit B (orange) removed for clarity. Lower panels show zoomed in view. In each view, interactions within hydrogen bonding distance and geometry are shown as dashed lines. Arrows are shown to help visualize sidechain rearrangements between the two structures.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Comparison of EmrE models with electron microscopy density.</title><p>(<bold>A</bold>) Crystal structure of EmrE<sub>3</sub> (orange and blue cartoon) overlaid with experimental electron microscopy density (cyan mesh contoured at 1.5σ) (<xref ref-type="bibr" rid="bib54">Ubarretxena-Belandia et al., 2003</xref>). (Panel repeated from <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref> to aid visual comparison). (<bold>B</bold>) NMR model of EmrE S64V (orange and blue cartoon) (<xref ref-type="bibr" rid="bib48">Shcherbakov et al., 2021</xref>) overlaid with experimental electron microscopy density shown in panel A (cyan mesh contoured at 1.5σ) (<xref ref-type="bibr" rid="bib54">Ubarretxena-Belandia et al., 2003</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig6-figsupp1-v2.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Comparison of experimental chemical shifts for EmrE (BMRB accession number 50411) with chemical shifts predicted from the crystallography model and NMR ensemble using LARMOR<sup>Cα</sup> (<xref ref-type="bibr" rid="bib17">Frank et al., 2015</xref>).</title><p>Residue number is plotted along the x-axis. The y-axis compares the relative difference between the experimental chemical shifts and the predicted chemical shifts for the crystallography and NMR models. For each C<sub>α</sub> position, the difference between the predicted and experimental chemical shifts was calculated (δ<sub>predicted, NMR model</sub>-δ<sub>experimental</sub> = Δ<sub>NMR</sub> and δ<sub>predicted, crystallography model</sub>-δ<sub>experimental</sub> = Δ<sub>crystal</sub>), and their relative magnitude compared (|Δ<sub>crystal</sub>|-|Δ<sub>NMR</sub>|). Values above the origin line indicate that the experimental chemical shifts are in better agreement with the predicted chemical shifts for the NMR model; values below the origin line indicate that the experimental chemical shifts are in better agreement with the predicted chemical shifts for the crystallography model. Residues in TM helices are shown as blue points, and residues in loop regions are shown as orange points. Residues that were not assigned in the NMR dataset, or that are mutated in either the NMR or crystal structures (E25, W31, V34, S64) are absent from this plot.</p><p><supplementary-material id="fig6s2sdata1"><label>Figure 6—figure supplement 2—source data 1.</label><caption><title>Chemical shift predictions for NMR model and crystallography model and NMR ensemble using LARMOR<sup>Cα</sup>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-76766-fig6-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig6-figsupp2-v2.tif"/></fig></fig-group><p>The difference in global conformation of the NMR and crystallography models is supported by a reorganization of the hydrogen bonding network in the substrate binding site (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). The heart of this change is a rotameric switch by Y60: In the crystal structures, Y60<sub>B</sub> participates in a pair of cross-subunit interactions, within coordination distance and geometry of E14<sub>A</sub> and W63<sub>A</sub> in the opposite subunit. In the NMR model, the same Y60<sub>B</sub> sidechain is assigned a different rotamer, its hydroxyl moving 6 Å along helix 1, so that it is now coordinating T18<sub>A</sub>, one helical turn away from E14<sub>A</sub>. The interaction with Y60<sub>B</sub> has displaced Y40<sub>A</sub> from its interaction with T18<sub>A</sub>. Helix 2<sub>A</sub> slides in a direction perpendicular to the membrane so that Y40<sub>A</sub> now encroaches on the position of F27<sub>A</sub> at the tip of loop 1, which is packed between helices 2<sub>A</sub> and 2<sub>B</sub> in the crystal structure. In the NMR ensemble, the displaced loop one is flexible and adopts various conformations. The helix density observed in the low-resolution EM dataset corresponds closely to the present crystallography models (Real space correlation coefficient (RSCC) = 0.67), and is less consistent with the NMR model (RSCC = 0.51; <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>; <xref ref-type="bibr" rid="bib54">Ubarretxena-Belandia et al., 2003</xref>).</p><p>The differences in conformation between the crystallography/EM datasets and the NMR model are unlikely to be due to membrane mimetic (which is shared for the EM and NMR datasets), the presence of monobodies (the EM data was collected without monobodies), or the S64V mutation used for NMR studies (NMR experiments showed little change in backbone configuration for this mutant <xref ref-type="bibr" rid="bib59">Wu et al., 2019</xref>). It is possible that the elevated temperature of the NMR experiments (45 ° C, compared to 20 ° C for crystallization) favor different states in a conformational ensemble. Previous EPR measurements may lend support to this possibility (<xref ref-type="bibr" rid="bib11">Dastvan et al., 2016</xref>). Those experiments showed that at pH 8, with TPP<sup>+</sup> bound, EmrE adopts a major conformation consistent with our current crystallography model. But when substrate is removed and the pH dropped to 5.5, EmrE’s conformational ensemble becomes more heterogeneous. The loops disengage and become more flexible, and a population emerges in which the two subunits have adopted a more-symmetric conformation. Perhaps the NMR experiments, which were performed at pH 5.5 (albeit with substrate) reflect that second conformation from the ensemble. Nevertheless, it is also worth noting that our crystallography model is not inconsistent with the backbone chemical shifts measured in bicelles based on structure-trained predictions of chemical shift (<xref ref-type="bibr" rid="bib17">Frank et al., 2015</xref>; <xref ref-type="bibr" rid="bib60">Xie et al., 2020</xref>).</p></sec><sec id="s3-3"><title>Comparison to prior functional studies of EmrE</title><p>EmrE has been studied in great breadth and depth. Full mutagenic scans coupled with growth assays (<xref ref-type="bibr" rid="bib2">Amadi et al., 2010</xref>; <xref ref-type="bibr" rid="bib19">Gutman et al., 2003</xref>; <xref ref-type="bibr" rid="bib32">Mordoch et al., 1999</xref>; <xref ref-type="bibr" rid="bib59">Wu et al., 2019</xref>), functional assays with reconstituted transporter (reviewed in <xref ref-type="bibr" rid="bib46">Schuldiner, 2009</xref>), and EPR and NMR spectroscopy experiments <xref ref-type="bibr" rid="bib2">Amadi et al., 2010</xref>; <xref ref-type="bibr" rid="bib4">Banigan et al., 2015</xref>; <xref ref-type="bibr" rid="bib11">Dastvan et al., 2016</xref>; <xref ref-type="bibr" rid="bib27">Leninger et al., 2019</xref>; <xref ref-type="bibr" rid="bib52">Thomas et al., 2018</xref> have all revealed detailed information about the positions that contribute to substrate binding and conformational change, even as the structural details were lacking. Our structure corroborates many of the specific predictions regarding sidechains that contribute to the binding pocket, including the importance of W63 for aromatic packing with the substrate (<xref ref-type="bibr" rid="bib14">Elbaz et al., 2005</xref>) and the cross-subunit engagement of Y60 (<xref ref-type="bibr" rid="bib55">Vermaas et al., 2018</xref>). Positions that are sensitive to mutation, including E14, T18, Y40, and L47 all line the binding pocket in our structures (<xref ref-type="bibr" rid="bib32">Mordoch et al., 1999</xref>; <xref ref-type="bibr" rid="bib43">Rotem et al., 2006</xref>; <xref ref-type="bibr" rid="bib45">Saleh et al., 2018</xref>; <xref ref-type="bibr" rid="bib59">Wu et al., 2019</xref>). Our structure also confirms other architectural features proposed from spectroscopic studies, including the deflection of loop two sidechain F27<sub>A</sub> toward the substrate bound in the binding pocket and the positioning of the portal-lining Y40 and F44 sidechains as an access point from the membrane to the substrate-binding site (<xref ref-type="bibr" rid="bib11">Dastvan et al., 2016</xref>). Our results also provide some insight into the observation that a single L51I or I62L mutation in one subunit of the EmrE dimer prevents conformational exchange (<xref ref-type="bibr" rid="bib27">Leninger et al., 2019</xref>). Both residues are located on transmembrane helices and are buried at protein interfaces in one monomer and accessible in the other (L51 to the aqueous binding pocket and I62 to the membrane). For Gdx-Clo, we previously posited that differential packing of the two monomers in the N-terminal half of helix three contributes to structural frustration and the resulting conformational exchange (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>). In EmrE, I62 is located in this same crucial region, and its mutation in only one monomer presumably disturbs the well-matched competition that occurs in the homodimer.</p><p>In addition to a substrate-free, pH 5.2 structure, we solved structures of EmrE with methyl viologen, harmane, Me-TPP<sup>+</sup>, TPP<sup>+</sup>, and benzyltrimethylammonium at pH values between 6.3 and 7.5. Experiments with EmrE in bicelles have suggested that a proton can bind simultaneously with TPP<sup>+</sup> with a pK<sub>a</sub> of 6.8 (<xref ref-type="bibr" rid="bib41">Robinson et al., 2017</xref>). In the NMR model, under conditions that favor simultaneous substrate and proton binding, F-TPP<sup>+</sup> is positioned higher in the binding pocket, 2 Å closer to E14<sub>B</sub> than protonated E14<sub>A</sub> (<xref ref-type="bibr" rid="bib48">Shcherbakov et al., 2021</xref>). In contrast, in our TPP<sup>+</sup>-bound structure, which was obtained at a pH of 7.25, TPP<sup>+</sup> is situated lower in the binding pocket and within 0.5 Å of the midpoint between the glutamates. It is thus probable that this crystal structure represents the doubly-deprotonated, substrate-bound state. It is also likely that both glutamates are deprotonated in the methyl viologen-bound structure, since this substrate bears a + 2 charge, making glutamate protonation more electrostatically unfavorable than in the presence of a monovalent substrate.</p><p>Protonation of the central glutamates has not been evaluated in the presence of monovalent substrates other than TPP<sup>+</sup>, and the E14 pK<sub>a</sub> values are likely to vary according to factors such as binding pocket solvation or charge delocalization on the substrate. For the Me-TPP<sup>+</sup>, harmane, and benzyltrimethylammonium-bound structures (pH 6.5, 7.1, and 7.25, respectively), the contribution of a substrate+ proton-bound population cannot be ruled out. However, the positioning of each of these substrates centered close to the midpoint between the E14 carboxylate groups, similar to TPP<sup>+</sup>, implies that in the major component of the population, both glutamates bear a negative charge.</p></sec><sec id="s3-4"><title>Sidechain movements accommodate diverse substrates</title><p>In addition to substantiating prior EmrE experiments, our structures also provide new molecular insights into the binding of structurally diverse substrates by EmrE. Methyl viologen, harmane, Me-TPP<sup>+</sup>, TPP<sup>+</sup>, and benzyltrimethylammonium have considerable structural differences, but are all accommodated in the EmrE binding site with only sidechain rearrangements. The closely related, but substantially more selective SMR family member, Gdx-Clo, provides a useful point of comparison to understand why EmrE can interact with this chemically diverse range of compounds. In Gdx-Clo, the substrate-binding glutamate sidechains are constrained by a polarized stack of hydrogen bond donors and acceptors that also includes W16<sub>Clo</sub>, S42<sub>Clo</sub>, and W62<sub>Clo</sub>. This hydrogen bonded network would be disrupted by the rotamerization of either E13<sub>Clo</sub> or W62<sub>Clo</sub>. We show that in Gdx-Clo, mutations to sidechains that contribute to the hydrogen bond stack seriously impair transport activity.</p><p>In contrast, in EmrE, the corresponding residues E14<sub>EmrE</sub> and W63<sub>EmrE</sub> are not constrained by such a stack of H-bond donors and acceptors. The current structures and SSM electrophysiology experiments both suggest that, in contrast to Gdx-Clo, a rigid H-bond network is not essential for substrate transport by EmrE, which remains functional when hydrogen bond capacity is eliminated at S43<sub>EmrE</sub> or W63<sub>EmrE</sub>. Without the stricter geometric constraints imposed by a polarized stack of sidechain hydrogen bond partners, both E14<sub>EmrE</sub> and W63<sub>EmrE</sub> have more flexibility to adopt different rotamers. Like a pair of calipers, the E14<sub>EmrE</sub> sidechains can move farther apart to accommodate large substrates such as quaternary ammoniums, or closer together for flat, aromatic substrates or substrates with small headgroups, like harmane and methyl viologen or singly substituted guanidinyl compounds. Similarly, W63<sub>EmrE</sub> has the space and flexibility to rotamerize, which can expand or narrow the binding pocket or allow W63<sub>EmrE</sub> to pack against the aromatic groups of bound substrates. These structural observations are in agreement with numerous prior studies that have demonstrated an important role for W63<sub>EmrE</sub> in transport of polyaromatic substrates (<xref ref-type="bibr" rid="bib2">Amadi et al., 2010</xref>; <xref ref-type="bibr" rid="bib14">Elbaz et al., 2005</xref>; <xref ref-type="bibr" rid="bib45">Saleh et al., 2018</xref>; <xref ref-type="bibr" rid="bib59">Wu et al., 2019</xref>). We note that although W63<sub>A, EmrE</sub> does change position in order to conform to different substrates, we did not always observe optimal pi stacking geometry between the substrate and the protein’s aromatic residues. Instead, substrate positioning appeared to optimize electrostatic interactions first, with all substrates situated directly between E14<sub>A, EmrE</sub> and E14<sub>B, EmrE</sub>.</p><p>Likewise, many EmrE substrates lack the capacity to donate strong hydrogen bonds, reducing the geometric constraints for protein-substrate interactions. Prior MD simulations suggested a dynamic interaction between TPP<sup>+</sup> and the EmrE-binding pocket (<xref ref-type="bibr" rid="bib55">Vermaas et al., 2018</xref>), and we expect that many compounds transported by EmrE have some mobility within the binding pocket. In the present structural experiments, we observe this explicitly for methyl viologen, which we identified in different but overlapping positions in the two transporters in the asymmetric unit.</p><p>While our experiments indicate that altering sidechain configuration is important to accommodate diverse substrates, backbone conformational changes do not need to be invoked to explain polyspecificity. Indeed, we do not see perturbations in EmrE’s main chain structure in the six different EmrE crystal structures resolved here. In addition, the general correspondence of the structures of EmrE and Gdx-Clo indicates that same tertiary architecture can also accommodate substrates with guanidinyl headgroups and/or alkyl tails. These observations also concur with observations from cryo-EM, which showed only minor differences in helix orientation and packing for the apo and TPP<sup>+</sup>-bound structures (<xref ref-type="bibr" rid="bib50">Tate et al., 2003</xref>). Thus, the crystallized conformation can accommodate substrates from major classes, including quaternary ammoniums, quaternary phosphoniums, planar polyaromatics, and substituted guanidiniums without substantial backbone rearrangement.</p></sec><sec id="s3-5"><title>Binding of benzalkonium<sup>+</sup> and other substrates with alkyl chains</title><p>Because benzalkonium is especially relevant as a common household and hospital antiseptic to which the Qac proteins provide resistance, we sought to visualize how this quaternary ammonium compound might interact with EmrE. Although we were unable to generate diffracting crystals of EmrE<sub>3</sub> in the presence of substrates with long alkyl tails, our current structure of EmrE<sub>3</sub> with benzyltrimethylammonium bound (a chemical homologue of benzalkonium with a methyl group in place of the alkyl chain), combined with our previous Gdx-Clo structure, provides a strong indication of how benzalkonium or other detergent-like substrates might bind.</p><p>In Gdx-Clo, octylGdm<sup>+</sup> binds such that its alkyl tail extends out of the aqueous binding pocket and into the membrane. In order to accommodate the alkyl tail, hydrophobic sidechains lining Gdx-Clo’s TM2 portal, including M39<sub>Clo</sub> and F43<sub>Clo</sub>, adopted alternative rotamers (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>). Although all the substrates in the present EmrE<sub>3</sub> structures were contained within the aqueous pocket, we similarly observe rotameric rearrangements of the TM2 sidechains in different structures, including Y40<sub>EmrE</sub> and F44<sub>EmrE</sub> (equivalent to Gdx-Clo’s M39<sub>Clo</sub> and F43<sub>Clo</sub>) in the harmane and methyl viologen structures. These observations suggest that, as in Gdx-Clo, in EmrE the sidechain packing at the TM2 interface is malleable, and that movements of these residues may remodel the TM2 portal to permit binding of substrates with detergent-like alkyl chains.</p><p>Indeed, when the quaternary ammonium headgroup of benzalkonium is superposed onto the experimentally determined position of benzyltrimethylammonium in the EmrE<sub>3</sub> binding pocket, the alkyl tail of benzalkonium extends towards the portal defined by the TM2 helices. Although the extended alkyl chain would clash with F44<sub>B, EmrE</sub>, positioning this sidechain in the ‘down’ rotamer (analogous to that adopted by F43<sub>B, Clo</sub> in Gdx-Clo) alleviates all clashes between the substrate and protein and provides unobstructed access for the alkyl tail to the membrane interior. <xref ref-type="fig" rid="fig7">Figure 7</xref> shows a proposed model of benzalkonium binding to EmrE prepared by aligning its headgroup with benzyltrimethylammonium followed by energy minimization of the complex using MMTK (<xref ref-type="bibr" rid="bib20">Hinsen, 2000</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Hypothetical model of benzalkonium binding to EmrE.</title><p>(<bold>A</bold>) Benzalkonium is shown in yellow stick representation. Sidechains from the A and B subunits are colored as before. The mainchain for helices lining the TM2 portal is shown in ribbon format, with the portal-lining sidechains shown as sticks. (<bold>B</bold>) Top-down view of binding site with benzalkonium. EmrE is sliced at the midpoint of the membrane. Comparisons of this model to the experimental models of EmrE in complex with benzyltrimethylammonium (PDB:7T00) and Gdx-Clo in complex with octylguanidinium (PDB:6WK9) are shown in <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Top down structures of EmrE in complex with benzyltrimethylammonium (PDB:7T00; model for benzalkonium headgroup binding) and Gdx-Clo in complex with octylguanidinium (PDB:6WK9; model for alkyl tail positioning).</title><p>Structures are sliced at the midpoint of the membrane, as in <xref ref-type="fig" rid="fig7">Figure 7</xref>. Dashed boxes indicate the headgroup and alkyl group positions used to prepare the hypothetical model of benzalkonium binding.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76766-fig7-figsupp1-v2.tif"/></fig></fig-group><p>Thus, we propose that sidechain rearrangements along the membrane portal also contribute to substrate polyspecificity by allowing hydrophobic substituents to extend out of the substrate-binding site and access the membrane interior. Similarly, we imagine that dipartite drugs transported by EmrE, such as propidium (a planar polyaromatic group linked to a tetraethyl ammonium) and dequalinium (two aromatic groups with a 10-carbon linker) may also utilize the portal for transport, with the protein-mediated transport of one moiety dragging its tethered lipophilic partner across the membrane.</p></sec><sec id="s3-6"><title>Conclusions</title><p>In summary, we have developed a multipurpose crystallization chaperone for SMR proteins and used this tool to resolve the first sidechain-resolution crystal structures of the bacterial SMR transporter, EmrE. In order to establish the structural basis of substrate polyspecificity, we resolved structures with five different substrates bound, including quaternary phosphoniums, planar aromatics, and a quaternary ammonium compound. We propose that, compared with more selective representatives of the SMR family, a relatively sparse hydrogen bond network among binding site residues in EmrE permits sidechain flexibility to conform to structurally diverse substrates.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">EmrE<sub>3</sub></td><td align="left" valign="bottom">Uniprot</td><td align="left" valign="bottom">P23895</td><td align="left" valign="bottom">Bears mutations E25N, W31I, V34M to bind monobody(this paper – see <xref ref-type="fig" rid="fig1">Figure 1</xref>)</td></tr><tr><td align="left" valign="bottom">Gene (<italic>Clostridiales</italic> bacterium oral taxon 876)</td><td align="left" valign="bottom">Gdx-Clo</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">ERI95081.1</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33247110/">33247110</ext-link></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">EmrE<sub>3</sub> in pET15b (plasmid)</td><td align="left" valign="bottom">This publication</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Expression vector for EmrE<sub>3</sub>. Available upon request.</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Gdx-Clo in pET21c (plasmid)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33247110/">33247110</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Expression vector for Gdx-Clo. Available upon request.</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom"><italic>E. coli</italic> polar lipids</td><td align="left" valign="bottom">Avanti, Alabaster, AL</td><td align="left" valign="bottom">#100600 C</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">n-decyl-β -D-maltopyranoside</td><td align="left" valign="bottom">Anatrace, Maumee, OH</td><td align="left" valign="bottom">D322</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Monobody L10 in pHBT1 (plasmid)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33247110/">33247110</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Expression vector for monobody L10.PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33247110/">33247110</ext-link>. Addgene ID: 183,406</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Bioinformatics and sequence analysis</title><p>Multiple sequence alignment was performed using MUSCLE (<xref ref-type="bibr" rid="bib13">Edgar, 2004</xref>). ConSurf was used for sequence conservation analysis (<xref ref-type="bibr" rid="bib3">Ashkenazy et al., 2016</xref>; <xref ref-type="bibr" rid="bib8">Berezin et al., 2004</xref>). For this analysis, SMR sequences from GEBA bacterial reference genomes (<xref ref-type="bibr" rid="bib35">Mukherjee et al., 2017</xref>) that were identified as probable homodimers based on genetic context (those encoded by a single gene in an operon) were further sorted into either Qac or Gdx subclasses using profile Hidden Markov Models built from the corresponding sequence clusters of the functionally annotated sequence similarity network described in <xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>. Representative sequences were selected for the alignments in <xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig4">4</xref> because (1) proteins have been characterized in transport or resistance assays and (2) sequences are distributed among different major clades of the phylogenetic tree (<xref ref-type="bibr" rid="bib22">Kermani et al., 2018</xref>).</p></sec><sec id="s4-2"><title>Protein purification and crystallization</title><p>L10 monobody was purified from inclusion bodies exactly as described in detail previously (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>). pET15b plasmids bearing the EmrE<sub>3</sub> coding sequence with an N-terminal hexahistidine tag and a thrombin cut site were transformed into <italic>E. coli</italic> C41 and grown overnight (15–18 hr) in Studier’s autoinduction media at 37 °C. Pellets were resuspended in breaking buffer (50 mM Tris-Cl pH 8.0, 100 mM NaCl, 10 mM tris(2-carboxyethyl)phosphine (TCEP)) with 400 μg DNase, 2 mM MgCl<sub>2</sub>, 1 mM PMSF, 1 mg/mL lysozyme, 25 μg pepstatin, and 500 μg leupeptin. Resuspended pellets were lysed by sonication and extracted with 2% n-Decyl-β-D-Maltopyranoside (DM) (Anatrace) for 2 hr at room temperature. Extract was clarified by centrifugation (16,000 rpm, 4 °C, 45 min), and loaded onto TALON cobalt resin equilibrated with wash buffer (20 mM tris-Cl pH 8.0, 100 mM NaCl, 5 mM DM) supplemented with 5 mM TCEP. Column was washed with wash buffer, and wash buffer supplemented with 10 mM imidazole before elution of EmrE<sub>3</sub> with wash buffer supplemented with 400 mM imidazole. After exchange into wash buffer using PD-10 desalting columns (GE Healthcare) His tags were cleaved with thrombin (1 U/mg EmrE<sub>3</sub>) overnight at room temperature (21 °C) prior to a final size exclusion purification step using a Superdex 200 column equilibrated with 10 mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES) pH 7.5, 100 mM NaCl, 4 mM DM.</p><p>For functional measurements, protein was reconstituted by dialysis as previously described (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>). For SSM electrophysiology experiments, proteoliposomes were prepared with 20 mg EPL per ml, and a 1:20 protein:lipid mass ratio. Proteoliposomes were aliquoted and stored at –80 ° C until use. For crystallography of EmrE<sub>3</sub>, monobody L10 and EmrE<sub>3</sub> were each concentrated to 10 mg/mL, and the L10 protein solution was supplemented with 4 mM DM. EmrE<sub>3</sub> and L10 were combined in a 2.1:1 molar ratio and supplemented with lauryldimethylamine oxide (LDAO, final concentration of 6.6 mM). The protein solution was mixed with an equal volume of crystallization solution (0.3 μL in 96-well plates). Crystals formed after approximately 4 weeks, and were frozen in liquid nitrogen before data collection. For crystallization with substrate, the EmrE<sub>3</sub>/monobody/LDAO solution was prepared as before, and substrate was added from a stock solution immediately before setting crystal trays (final concentrations of 1 mM for methyl viologen, 500 μM for harmane, 300 μM for benzyltrimethylammonium, 100 μM for TPP<sup>+</sup>, or 300 μM for MeTPP<sup>+</sup>). The low pH EmrE<sub>3</sub> crystals grew in 200 mM NaCl, 100 mM sodium cacodylate, pH 5.2, 34% PEG 600. The substrate-bound EmrE<sub>3</sub> crystals grew in 100 mM LiNO<sub>3</sub> or 100 mM NH<sub>4</sub>SO<sub>4</sub>, 100 mM ADA, pH 6.5 or 100 mM HEPES, pH 7.1–7.3, and 30–35% PEG 600. Gdx-Clo protein and crystals were prepared exactly as described previously (<xref ref-type="bibr" rid="bib23">Kermani et al., 2020</xref>). Crystals grew in 100 mM calcium acetate, 100 mM sodium acetate, pH 5.0, 40% PEG600.</p></sec><sec id="s4-3"><title>Structure determination and analysis</title><p>Crystallography data was collected at the Life Sciences Collaborative Access Team beamline 21-ID-D at the Advanced Photon Source, Argonne National Laboratory. Diffraction data were processed and scaled using Mosflm 7.3 (<xref ref-type="bibr" rid="bib5">Battye et al., 2011</xref>) or DIALS (<xref ref-type="bibr" rid="bib58">Winter et al., 2018</xref>). Crystals diffracted anisotropically, and electron density maps were improved by anisotropic truncation of the unmerged data using the Staraniso webserver (<xref ref-type="bibr" rid="bib53">Tickle et al., 2018</xref>) with a cutoff level of 1.2–1.8 for the local <italic>I/σ&lt; I</italic> &gt; . For the low pH EmrE<sub>3</sub> dataset, phases were determined using molecular replacement with Phaser (<xref ref-type="bibr" rid="bib30">McCoy et al., 2007</xref>), using the first three helices of Gdx-Clo and the L10 monobody structures (PDB:6WK8) as search models. Loop 3, helix 4, and the C-terminal loop were built into the experimental electron density using Coot (<xref ref-type="bibr" rid="bib15">Emsley et al., 2010</xref>), with iterative rounds of refinement in Phenix (<xref ref-type="bibr" rid="bib29">Liebschner et al., 2019</xref>) and Refmac (<xref ref-type="bibr" rid="bib37">Murshudov et al., 2011</xref>). For the low pH Gdx-Clo structure, Gdx-Clo and the L10 monobody structures (PDB:6WK8) were used as molecular replacement search models. Models were validated using Molprobity (<xref ref-type="bibr" rid="bib56">Williams et al., 2018</xref>) and by preparing composite omit maps in Phenix, omitting 5% of the model at a time (<xref ref-type="bibr" rid="bib51">Terwilliger et al., 2008</xref>). The substrate-bound structures were phased using molecular replacement with monobody L10 and the A and B subunits of the initial EmrE<sub>3</sub> model as the search models. Proteins typically crystallized in C121, although the methyl viologen-bound EmrE<sub>3</sub> structure and the low pH Gdx-Clo crystallized in P1. For both, the unit cell contained two pseudosymmetric copies of the transporter-monobody complex. The angle of the bend in TM3 was analyzed using Kink Finder (<xref ref-type="bibr" rid="bib57">Wilman et al., 2014</xref>).</p></sec><sec id="s4-4"><title>Microscale thermophoresis</title><p>Monobody L10 was labeled at a unique, introduced cysteine, A13C, with fluorescein maleimide. Binding to EmrE<sub>3</sub> was measured using microscale thermophoresis (Nanotemper, Munich, Germany). For these experiments, labeled monobody was held constant at 2 μM, and the concentration of EmrE<sub>3</sub> was varied from 30 nM to 100 μM. Buffer contained 100 mM NaCl, 10 mM HEPES, pH 7, 4 mM DM, and 50 μg/mL bovine serum albumin. Samples were incubated at least 30 min prior to measurement of binding interactions. Experiments were performed using three independent sample preparations and fit to a one site binding equilibrium with total L10 as the experimental variable:<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mi>M</mml:mi><mml:mi>S</mml:mi><mml:mi>T</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mfenced close="]" open="[" separators="|"><mml:mrow><mml:mi>E</mml:mi><mml:mi>m</mml:mi><mml:mi>r</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>M</mml:mi><mml:mi>S</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mfrac><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi><mml:mi>S</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mi> </mml:mi><mml:msub><mml:mrow><mml:mi>M</mml:mi><mml:mi>S</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:mfenced separators="|"><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mfrac><mml:mrow><mml:mo>[</mml:mo><mml:mi>E</mml:mi><mml:mi>m</mml:mi><mml:mi>r</mml:mi><mml:mi>E</mml:mi><mml:mo>]</mml:mo></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mi>L</mml:mi><mml:mn>10</mml:mn><mml:mo>]</mml:mo></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mi>L</mml:mi><mml:mn>10</mml:mn><mml:mo>]</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced><mml:mfenced close="]" open="[" separators="|"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi> </mml:mi><mml:msqrt><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mn>4</mml:mn><mml:mfrac><mml:mrow><mml:mo>[</mml:mo><mml:mi>E</mml:mi><mml:mi>m</mml:mi><mml:mi>r</mml:mi><mml:mi>E</mml:mi><mml:mo>]</mml:mo></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mi>L</mml:mi><mml:mn>10</mml:mn><mml:mo>]</mml:mo></mml:mrow></mml:mfrac></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mfrac><mml:mrow><mml:mo>[</mml:mo><mml:mi>E</mml:mi><mml:mi>m</mml:mi><mml:mi>r</mml:mi><mml:mi>E</mml:mi><mml:mo>]</mml:mo></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mi>L</mml:mi><mml:mn>10</mml:mn><mml:mo>]</mml:mo></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mi> </mml:mi><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mi>L</mml:mi><mml:mn>10</mml:mn><mml:mo>]</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:msqrt></mml:mrow></mml:mfenced></mml:math></disp-formula></p><p>where MST([EmrE]) is the MST signal as a function of total EmrE added to a fixed concentration of labelled L10 monobody, and MST<sub>0</sub> and MST<sub>f</sub> are the arbitrary initial and final MST fluorescence signals.</p></sec><sec id="s4-5"><title>SSM electrophysiology</title><p>SSM electrophysiology was conducted using a SURFE<sup>2</sup>R N1 instrument (Nanion Technologies, Munich, Germany) according to published protocols (<xref ref-type="bibr" rid="bib7">Bazzone and Barthmes, 2020</xref>; <xref ref-type="bibr" rid="bib6">Bazzone et al., 2017</xref>). The sensor was alkylated and painted with lipid solution (7.5 µg/µl 1,2-diphytanoyl-sn-glycero-3-phosphocholine in n-decane), followed immediately by addition of recording buffer (100 mM KCl, 100 mM KPO<sub>4</sub>, pH 7.5). For measurements in the presence of monobody, buffers also contained 50 μg bovine serum albumin/mL. Proteoliposomes were applied to the sensor surface and centrifuged at 2500 x g for 30 min. Before experiments, sensors were checked for conductance and capacitance using SURFE<sup>2</sup>R software protocols. Sensors for which capacitance and conductance measurements were outside an acceptable range (10–40 nF capacitance, 1–5 nS conductance) were not used for experiments. Sensors were periodically rechecked for quality during the course of an experiment. When multiple measurements were performed on a single sensor, currents elicited by a reference compound were measured at the outset of the experiment and again after collecting data on test compounds. If currents differed by more than 10% between the first and last perfusions, this indicated that the proteoliposomes associated with the sensor had not remained stable over the course of the experiment, and data collected in this series was discarded. Between measurements, sensors were perfused with substrate-free solution for 2 s; observation of capacitive currents with opposite polarity indicated substrate efflux from the proteoliposomes and a return to the resting condition.</p></sec><sec id="s4-6"><title>NMR chemical shift prediction</title><p>The chemical shifts of the C<sub>α</sub> atoms of the NMR ensemble and the unliganded crystallography model were predicted using LARMOR<sup>Cα</sup> (<xref ref-type="bibr" rid="bib17">Frank et al., 2015</xref>) as implemented with PyShifts (<xref ref-type="bibr" rid="bib60">Xie et al., 2020</xref>).</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>is listed as inventor for patents (US9512199 B2 and related patents and applications) covering aspects of the monobody technology filed by the University of Chicago and Novartis</p></fn><fn fn-type="COI-statement" id="conf3"><p>is listed as inventor for patents (US9512199 B2 and related patents and applications) covering aspects of the monobody technology filed by the University of Chicago and Novartis. Is a scientific advisory board member and holds equity in and receives consulting fees from Black Diamond Therapeutics; receives research funding from Puretech Health and Argenx BVBA</p></fn><fn fn-type="COI-statement" id="conf4"><p>Reviewing editor, <italic>eLife</italic></p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Investigation, Methodology, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Funding acquisition, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Supervision, Visualization, Writing - original draft</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-76766-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Atomic coordinates for the crystal structures have been deposited in the Protein Data Bank under accession numbers 7MH6 (EmrE3/L10), 7MGX (EmrE3/L10/methyl viologen), 7SVX (EmrE3/L10/harmane), 7SSU (EmrE3/L10/MeTPP+), 7SV9 (EmrE3/L10/TPP+), 7T00 (EmrE3/L10/benzyltrimethylammonium) and 7SZT (Gdx-Clo/L10). All other data generated or analyzed during this study are included in the manuscript and supporting file; source data files have been provided for Figures 1 and 5.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Kermani</surname><given-names>AA</given-names></name><name><surname>Stockbridge</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Structure of EmrE-D3 mutant in complex with monobody L10 in low pH (protonated state)</data-title><source>RCSB Protein Data Bank</source><pub-id pub-id-type="accession" xlink:href="https://www.rcsb.org/structure/7MH6">7MH6</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Kermani</surname><given-names>AA</given-names></name><name><surname>Stockbridge</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Structure of EmrE-D3 mutant in complex with monobody L10 and methyl viologen</data-title><source>RCSB Protein Data Bank</source><pub-id pub-id-type="accession" xlink:href="https://www.rcsb.org/structure/7MGX">7MGX</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Kermani</surname><given-names>AA</given-names></name><name><surname>Stockbridge</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Structure of EmrE-D3 mutant in complex with monobody L10 and harmane</data-title><source>RCSB Protein Data Bank</source><pub-id pub-id-type="accession" xlink:href="https://www.rcsb.org/structure/7SVX">7SVX</pub-id></element-citation></p><p><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Kermani</surname><given-names>AA</given-names></name><name><surname>Stockbridge</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Structure of EmrE-D3 mutant in complex with monobody L10 and methyltriphenylphosphonium</data-title><source>RCSB Protein Data Bank</source><pub-id pub-id-type="accession" xlink:href="https://www.rcsb.org/structure/7SSU">7SSU</pub-id></element-citation></p><p><element-citation id="dataset5" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Kermani</surname><given-names>AA</given-names></name><name><surname>Stockbridge</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Structure of EmrE-D3 mutant in complex with monobody L10 and TPP</data-title><source>RCSB Protein Data Bank</source><pub-id pub-id-type="accession" xlink:href="https://www.rcsb.org/structure/7SV9">7SV9</pub-id></element-citation></p><p><element-citation id="dataset6" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Kermani</surname><given-names>AA</given-names></name><name><surname>Stockbridge</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Structure of EmrE-D3 mutant in complex with monobody L10 and benzyltrimethylammonium</data-title><source>RCSB Protein Data Bank</source><pub-id pub-id-type="accession" xlink:href="https://www.rcsb.org/structure/7T00">7T00</pub-id></element-citation></p><p><element-citation id="dataset7" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Kermani</surname><given-names>AA</given-names></name><name><surname>Stockbridge</surname><given-names>RB</given-names></name><name><surname>Burata</surname><given-names>OE</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Crystal structure of Gdx-Clo from Small Multidrug Resistance family of transporters in low pH (protonated state)</data-title><source>RCSB Protein Data Bank</source><pub-id pub-id-type="accession" xlink:href="https://www.rcsb.org/structure/7SZT">7SZT</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank the Stockbridge lab for comments on the project and manuscript, and we are grateful to Aaron Frank (University of Michigan) for helpful conversations about chemical shift-based comparisons of the structures. Funding: This work was supported by NSF CAREER award 1845012 to RBS and R01 CA194864 to SK. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). RBS is a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adam</surname><given-names>Y</given-names></name><name><surname>Tayer</surname><given-names>N</given-names></name><name><surname>Rotem</surname><given-names>D</given-names></name><name><surname>Schreiber</surname><given-names>G</given-names></name><name><surname>Schuldiner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The fast release of sticky protons: kinetics of substrate binding and proton release in a multidrug transporter</article-title><source>PNAS</source><volume>104</volume><fpage>17989</fpage><lpage>17994</lpage><pub-id pub-id-type="doi">10.1073/pnas.0704425104</pub-id><pub-id pub-id-type="pmid">17984053</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amadi</surname><given-names>ST</given-names></name><name><surname>Koteiche</surname><given-names>HA</given-names></name><name><surname>Mishra</surname><given-names>S</given-names></name><name><surname>McHaourab</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Structure, dynamics, and substrate-induced conformational changes of the multidrug transporter EmrE in liposomes</article-title><source>The Journal of Biological Chemistry</source><volume>285</volume><fpage>26710</fpage><lpage>26718</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.132621</pub-id><pub-id pub-id-type="pmid">20551331</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashkenazy</surname><given-names>H</given-names></name><name><surname>Abadi</surname><given-names>S</given-names></name><name><surname>Martz</surname><given-names>E</given-names></name><name><surname>Chay</surname><given-names>O</given-names></name><name><surname>Mayrose</surname><given-names>I</given-names></name><name><surname>Pupko</surname><given-names>T</given-names></name><name><surname>Ben-Tal</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>W344</fpage><lpage>W350</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw408</pub-id><pub-id pub-id-type="pmid">27166375</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banigan</surname><given-names>JR</given-names></name><name><surname>Gayen</surname><given-names>A</given-names></name><name><surname>Cho</surname><given-names>MK</given-names></name><name><surname>Traaseth</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A structured loop modulates coupling between the substrate-binding and dimerization domains in the multidrug resistance transporter EmrE</article-title><source>The Journal of Biological Chemistry</source><volume>290</volume><fpage>805</fpage><lpage>814</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.601963</pub-id><pub-id pub-id-type="pmid">25406320</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battye</surname><given-names>TGG</given-names></name><name><surname>Kontogiannis</surname><given-names>L</given-names></name><name><surname>Johnson</surname><given-names>O</given-names></name><name><surname>Powell</surname><given-names>HR</given-names></name><name><surname>Leslie</surname><given-names>AGW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM</article-title><source>Acta Crystallographica. Section D, Biological Crystallography</source><volume>67</volume><fpage>271</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1107/S0907444910048675</pub-id><pub-id pub-id-type="pmid">21460445</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazzone</surname><given-names>A</given-names></name><name><surname>Barthmes</surname><given-names>M</given-names></name><name><surname>Fendler</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SSM-Based Electrophysiology for Transporter Research</article-title><source>Methods in Enzymology</source><volume>594</volume><fpage>31</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/bs.mie.2017.05.008</pub-id><pub-id pub-id-type="pmid">28779843</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazzone</surname><given-names>A</given-names></name><name><surname>Barthmes</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Functional Characterization of SLC Transporters Using Solid Supported Membranes</article-title><source>Methods in Molecular Biology (Clifton, N.J.)</source><volume>2168</volume><fpage>73</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-0724-4_4</pub-id><pub-id pub-id-type="pmid">33582988</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berezin</surname><given-names>C</given-names></name><name><surname>Glaser</surname><given-names>F</given-names></name><name><surname>Rosenberg</surname><given-names>J</given-names></name><name><surname>Paz</surname><given-names>I</given-names></name><name><surname>Pupko</surname><given-names>T</given-names></name><name><surname>Fariselli</surname><given-names>P</given-names></name><name><surname>Casadio</surname><given-names>R</given-names></name><name><surname>Ben-Tal</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>ConSeq: the identification of functionally and structurally important residues in protein sequences</article-title><source>Bioinformatics (Oxford, England)</source><volume>20</volume><fpage>1322</fpage><lpage>1324</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bth070</pub-id><pub-id pub-id-type="pmid">14871869</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brill</surname><given-names>S</given-names></name><name><surname>Sade-Falk</surname><given-names>O</given-names></name><name><surname>Elbaz-Alon</surname><given-names>Y</given-names></name><name><surname>Schuldiner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Specificity determinants in small multidrug transporters</article-title><source>Journal of Molecular Biology</source><volume>427</volume><fpage>468</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2014.11.015</pub-id><pub-id pub-id-type="pmid">25479374</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YJ</given-names></name><name><surname>Pornillos</surname><given-names>O</given-names></name><name><surname>Lieu</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>AP</given-names></name><name><surname>Chang</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>X-ray structure of EmrE supports dual topology model</article-title><source>PNAS</source><volume>104</volume><fpage>18999</fpage><lpage>19004</lpage><pub-id pub-id-type="doi">10.1073/pnas.0709387104</pub-id><pub-id pub-id-type="pmid">18024586</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dastvan</surname><given-names>R</given-names></name><name><surname>Fischer</surname><given-names>AW</given-names></name><name><surname>Mishra</surname><given-names>S</given-names></name><name><surname>Meiler</surname><given-names>J</given-names></name><name><surname>Mchaourab</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Protonation-dependent conformational dynamics of the multidrug transporter EmrE</article-title><source>PNAS</source><volume>113</volume><fpage>1220</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1073/pnas.1520431113</pub-id><pub-id pub-id-type="pmid">26787875</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutka</surname><given-names>P</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>de Waal</surname><given-names>PW</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhuang</surname><given-names>Y</given-names></name><name><surname>Melcher</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>HE</given-names></name><name><surname>Kossiakoff</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Development of “Plug and Play” Fiducial Marks for Structural Studies of GPCR Signaling Complexes by Single-Particle Cryo-EM</article-title><source>Structure (London, England</source><volume>27</volume><fpage>1862</fpage><lpage>1874</lpage><pub-id pub-id-type="doi">10.1016/j.str.2019.10.004</pub-id><pub-id pub-id-type="pmid">31669042</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>MUSCLE: multiple sequence alignment with high accuracy and high throughput</article-title><source>Nucleic Acids Research</source><volume>32</volume><fpage>1792</fpage><lpage>1797</lpage><pub-id pub-id-type="doi">10.1093/nar/gkh340</pub-id><pub-id pub-id-type="pmid">15034147</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elbaz</surname><given-names>Y</given-names></name><name><surname>Tayer</surname><given-names>N</given-names></name><name><surname>Steinfels</surname><given-names>E</given-names></name><name><surname>Steiner-Mordoch</surname><given-names>S</given-names></name><name><surname>Schuldiner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Substrate-induced tryptophan fluorescence changes in EmrE, the smallest ion-coupled multidrug transporter</article-title><source>Biochemistry</source><volume>44</volume><fpage>7369</fpage><lpage>7377</lpage><pub-id pub-id-type="doi">10.1021/bi050356t</pub-id><pub-id pub-id-type="pmid">15882076</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Lohkamp</surname><given-names>B</given-names></name><name><surname>Scott</surname><given-names>WG</given-names></name><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Features and development of Coot</article-title><source>Acta Crystallographica. Section D, Biological Crystallography</source><volume>66</volume><fpage>486</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id><pub-id pub-id-type="pmid">20383002</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleishman</surname><given-names>SJ</given-names></name><name><surname>Harrington</surname><given-names>SE</given-names></name><name><surname>Enosh</surname><given-names>A</given-names></name><name><surname>Halperin</surname><given-names>D</given-names></name><name><surname>Tate</surname><given-names>CG</given-names></name><name><surname>Ben-Tal</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Quasi-symmetry in the cryo-EM structure of EmrE provides the key to modeling its transmembrane domain</article-title><source>Journal of Molecular Biology</source><volume>364</volume><fpage>54</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2006.08.072</pub-id><pub-id pub-id-type="pmid">17005200</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>AT</given-names></name><name><surname>Law</surname><given-names>SM</given-names></name><name><surname>Ahlstrom</surname><given-names>LS</given-names></name><name><surname>Brooks</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Predicting protein backbone chemical shifts from Cα coordinates: extracting high resolution experimental observables from low resolution models</article-title><source>Journal of Chemical Theory and Computation</source><volume>11</volume><fpage>325</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1021/ct5009125</pub-id><pub-id pub-id-type="pmid">25620895</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillings</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Class 1 integrons as invasive species</article-title><source>Current Opinion in Microbiology</source><volume>38</volume><fpage>10</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2017.03.002</pub-id><pub-id pub-id-type="pmid">28414952</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutman</surname><given-names>N</given-names></name><name><surname>Steiner-Mordoch</surname><given-names>S</given-names></name><name><surname>Schuldiner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>An amino acid cluster around the essential Glu-14 is part of the substrate- and proton-binding domain of EmrE, a multidrug transporter from <italic>Escherichia coli</italic></article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>16082</fpage><lpage>16087</lpage><pub-id pub-id-type="doi">10.1074/jbc.M213120200</pub-id><pub-id pub-id-type="pmid">12590142</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinsen</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The molecular modeling toolkit: A new approach to molecular simulations</article-title><source>Journal of Computational Chemistry</source><volume>21</volume><fpage>79</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(20000130)21:2&lt;79::AID-JCC1&gt;3.0.CO;2-B</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurasz</surname><given-names>J</given-names></name><name><surname>Bagiński</surname><given-names>M</given-names></name><name><surname>Czub</surname><given-names>J</given-names></name><name><surname>Wieczór</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Molecular mechanism of proton-coupled ligand translocation by the bacterial efflux pump EmrE</article-title><source>PLOS Computational Biology</source><volume>17</volume><elocation-id>e1009454</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1009454</pub-id><pub-id pub-id-type="pmid">34613958</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kermani</surname><given-names>AA</given-names></name><name><surname>Macdonald</surname><given-names>CB</given-names></name><name><surname>Gundepudi</surname><given-names>R</given-names></name><name><surname>Stockbridge</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Guanidinium export is the primal function of SMR family transporters</article-title><source>PNAS</source><volume>115</volume><fpage>3060</fpage><lpage>3065</lpage><pub-id pub-id-type="doi">10.1073/pnas.1719187115</pub-id><pub-id pub-id-type="pmid">29507227</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kermani</surname><given-names>AA</given-names></name><name><surname>Macdonald</surname><given-names>CB</given-names></name><name><surname>Burata</surname><given-names>OE</given-names></name><name><surname>Ben Koff</surname><given-names>B</given-names></name><name><surname>Koide</surname><given-names>A</given-names></name><name><surname>Denbaum</surname><given-names>E</given-names></name><name><surname>Koide</surname><given-names>S</given-names></name><name><surname>Stockbridge</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The structural basis of promiscuity in small multidrug resistance transporters</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>6064</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-19820-8</pub-id><pub-id pub-id-type="pmid">33247110</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koide</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Engineering of recombinant crystallization chaperones</article-title><source>Current Opinion in Structural Biology</source><volume>19</volume><fpage>449</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2009.04.008</pub-id><pub-id pub-id-type="pmid">19477632</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koide</surname><given-names>A</given-names></name><name><surname>Wojcik</surname><given-names>J</given-names></name><name><surname>Gilbreth</surname><given-names>RN</given-names></name><name><surname>Hoey</surname><given-names>RJ</given-names></name><name><surname>Koide</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Teaching an old scaffold new tricks: monobodies constructed using alternative surfaces of the FN3 scaffold</article-title><source>Journal of Molecular Biology</source><volume>415</volume><fpage>393</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2011.12.019</pub-id><pub-id pub-id-type="pmid">22198408</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koldobskaya</surname><given-names>Y</given-names></name><name><surname>Duguid</surname><given-names>EM</given-names></name><name><surname>Shechner</surname><given-names>DM</given-names></name><name><surname>Suslov</surname><given-names>NB</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Sidhu</surname><given-names>SS</given-names></name><name><surname>Bartel</surname><given-names>DP</given-names></name><name><surname>Koide</surname><given-names>S</given-names></name><name><surname>Kossiakoff</surname><given-names>AA</given-names></name><name><surname>Piccirilli</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A portable RNA sequence whose recognition by A synthetic antibody facilitates structural determination</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>18</volume><fpage>100</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1038/nsmb.1945</pub-id><pub-id pub-id-type="pmid">21151117</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leninger</surname><given-names>M</given-names></name><name><surname>Sae Her</surname><given-names>A</given-names></name><name><surname>Traaseth</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Inducing conformational preference of the membrane protein transporter EmrE through conservative mutations</article-title><source>eLife</source><volume>8</volume><elocation-id>e48909</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.48909</pub-id><pub-id pub-id-type="pmid">31637997</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Sae Her</surname><given-names>A</given-names></name><name><surname>Traaseth</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Asymmetric protonation of glutamate residues drives a preferred transport pathway in EmrE</article-title><source>PNAS</source><volume>118</volume><elocation-id>2110790118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2110790118</pub-id><pub-id pub-id-type="pmid">34607959</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liebschner</surname><given-names>D</given-names></name><name><surname>Afonine</surname><given-names>PV</given-names></name><name><surname>Baker</surname><given-names>ML</given-names></name><name><surname>Bunkóczi</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>VB</given-names></name><name><surname>Croll</surname><given-names>TI</given-names></name><name><surname>Hintze</surname><given-names>B</given-names></name><name><surname>Hung</surname><given-names>LW</given-names></name><name><surname>Jain</surname><given-names>S</given-names></name><name><surname>McCoy</surname><given-names>AJ</given-names></name><name><surname>Moriarty</surname><given-names>NW</given-names></name><name><surname>Oeffner</surname><given-names>RD</given-names></name><name><surname>Poon</surname><given-names>BK</given-names></name><name><surname>Prisant</surname><given-names>MG</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name><name><surname>Richardson</surname><given-names>JS</given-names></name><name><surname>Richardson</surname><given-names>DC</given-names></name><name><surname>Sammito</surname><given-names>MD</given-names></name><name><surname>Sobolev</surname><given-names>OV</given-names></name><name><surname>Stockwell</surname><given-names>DH</given-names></name><name><surname>Terwilliger</surname><given-names>TC</given-names></name><name><surname>Urzhumtsev</surname><given-names>AG</given-names></name><name><surname>Videau</surname><given-names>LL</given-names></name><name><surname>Williams</surname><given-names>CJ</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix</article-title><source>Acta Crystallographica. Section D, Structural Biology</source><volume>75</volume><fpage>861</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1107/S2059798319011471</pub-id><pub-id pub-id-type="pmid">31588918</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCoy</surname><given-names>AJ</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Winn</surname><given-names>MD</given-names></name><name><surname>Storoni</surname><given-names>LC</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Phaser crystallographic software</article-title><source>Journal of Applied Crystallography</source><volume>40</volume><fpage>658</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1107/S0021889807021206</pub-id><pub-id pub-id-type="pmid">19461840</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIlwain</surname><given-names>BC</given-names></name><name><surname>Erwin</surname><given-names>AL</given-names></name><name><surname>Davis</surname><given-names>AR</given-names></name><name><surname>Ben Koff</surname><given-names>B</given-names></name><name><surname>Chang</surname><given-names>L</given-names></name><name><surname>Bylund</surname><given-names>T</given-names></name><name><surname>Chuang</surname><given-names>GY</given-names></name><name><surname>Kwong</surname><given-names>PD</given-names></name><name><surname>Ohi</surname><given-names>MD</given-names></name><name><surname>Lai</surname><given-names>YT</given-names></name><name><surname>Stockbridge</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>N-terminal Transmembrane-Helix Epitope Tag for X-ray Crystallography and Electron Microscopy of Small Membrane Proteins</article-title><source>Journal of Molecular Biology</source><volume>433</volume><elocation-id>166909</elocation-id><pub-id pub-id-type="doi">10.1016/j.jmb.2021.166909</pub-id><pub-id pub-id-type="pmid">33676924</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mordoch</surname><given-names>SS</given-names></name><name><surname>Granot</surname><given-names>D</given-names></name><name><surname>Lebendiker</surname><given-names>M</given-names></name><name><surname>Schuldiner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Scanning cysteine accessibility of EmrE, an H+-coupled multidrug transporter from <italic>Escherichia coli</italic>, reveals a hydrophobic pathway for solutes</article-title><source>The Journal of Biological Chemistry</source><volume>274</volume><fpage>19480</fpage><lpage>19486</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.27.19480</pub-id><pub-id pub-id-type="pmid">10383465</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>EA</given-names></name><name><surname>DeKoster</surname><given-names>GT</given-names></name><name><surname>Dutta</surname><given-names>S</given-names></name><name><surname>Vafabakhsh</surname><given-names>R</given-names></name><name><surname>Clarkson</surname><given-names>MW</given-names></name><name><surname>Bahl</surname><given-names>A</given-names></name><name><surname>Kern</surname><given-names>D</given-names></name><name><surname>Ha</surname><given-names>T</given-names></name><name><surname>Henzler-Wildman</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Antiparallel EmrE exports drugs by exchanging between asymmetric structures</article-title><source>Nature</source><volume>481</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1038/nature10703</pub-id><pub-id pub-id-type="pmid">22178925</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>EA</given-names></name><name><surname>Robinson</surname><given-names>AE</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Henzler-Wildman</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Asymmetric protonation of EmrE</article-title><source>The Journal of General Physiology</source><volume>146</volume><fpage>445</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1085/jgp.201511404</pub-id><pub-id pub-id-type="pmid">26573622</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Seshadri</surname><given-names>R</given-names></name><name><surname>Varghese</surname><given-names>NJ</given-names></name><name><surname>Eloe-Fadrosh</surname><given-names>EA</given-names></name><name><surname>Meier-Kolthoff</surname><given-names>JP</given-names></name><name><surname>Göker</surname><given-names>M</given-names></name><name><surname>Coates</surname><given-names>RC</given-names></name><name><surname>Hadjithomas</surname><given-names>M</given-names></name><name><surname>Pavlopoulos</surname><given-names>GA</given-names></name><name><surname>Paez-Espino</surname><given-names>D</given-names></name><name><surname>Yoshikuni</surname><given-names>Y</given-names></name><name><surname>Visel</surname><given-names>A</given-names></name><name><surname>Whitman</surname><given-names>WB</given-names></name><name><surname>Garrity</surname><given-names>GM</given-names></name><name><surname>Eisen</surname><given-names>JA</given-names></name><name><surname>Hugenholtz</surname><given-names>P</given-names></name><name><surname>Pati</surname><given-names>A</given-names></name><name><surname>Ivanova</surname><given-names>NN</given-names></name><name><surname>Woyke</surname><given-names>T</given-names></name><name><surname>Klenk</surname><given-names>H-P</given-names></name><name><surname>Kyrpides</surname><given-names>NC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>1,003 reference genomes of bacterial and archaeal isolates expand coverage of the tree of life</article-title><source>Nature Biotechnology</source><volume>35</volume><fpage>676</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1038/nbt.3886</pub-id><pub-id pub-id-type="pmid">28604660</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Erramilli</surname><given-names>SK</given-names></name><name><surname>Ammirati</surname><given-names>M</given-names></name><name><surname>Alvarez</surname><given-names>FJD</given-names></name><name><surname>Fennell</surname><given-names>KF</given-names></name><name><surname>Purdy</surname><given-names>MD</given-names></name><name><surname>Skrobek</surname><given-names>BM</given-names></name><name><surname>Radziwon</surname><given-names>K</given-names></name><name><surname>Coukos</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Dutka</surname><given-names>P</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Yeager</surname><given-names>M</given-names></name><name><surname>Eric Xu</surname><given-names>H</given-names></name><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Kossiakoff</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Synthetic antibodies against BRIL as universal fiducial marks for single-particle cryoEM structure determination of membrane proteins</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>1598</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-15363-0</pub-id><pub-id pub-id-type="pmid">32221310</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murshudov</surname><given-names>GN</given-names></name><name><surname>Skubák</surname><given-names>P</given-names></name><name><surname>Lebedev</surname><given-names>AA</given-names></name><name><surname>Pannu</surname><given-names>NS</given-names></name><name><surname>Steiner</surname><given-names>RA</given-names></name><name><surname>Nicholls</surname><given-names>RA</given-names></name><name><surname>Winn</surname><given-names>MD</given-names></name><name><surname>Long</surname><given-names>F</given-names></name><name><surname>Vagin</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>REFMAC5 for the refinement of macromolecular crystal structures</article-title><source>Acta Crystallographica. Section D, Biological Crystallography</source><volume>67</volume><fpage>355</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1107/S0907444911001314</pub-id><pub-id pub-id-type="pmid">21460454</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>JW</given-names></name><name><surname>Atilho</surname><given-names>RM</given-names></name><name><surname>Sherlock</surname><given-names>ME</given-names></name><name><surname>Stockbridge</surname><given-names>RB</given-names></name><name><surname>Breaker</surname><given-names>RR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Metabolism of Free Guanidine in Bacteria Is Regulated by a Widespread Riboswitch Class</article-title><source>Molecular Cell</source><volume>65</volume><fpage>220</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.11.019</pub-id><pub-id pub-id-type="pmid">27989440</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ovchinnikov</surname><given-names>V</given-names></name><name><surname>Stone</surname><given-names>TA</given-names></name><name><surname>Deber</surname><given-names>CM</given-names></name><name><surname>Karplus</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structure of the EmrE multidrug transporter and its use for inhibitor peptide design</article-title><source>PNAS</source><volume>115</volume><fpage>E7932</fpage><lpage>E7941</lpage><pub-id pub-id-type="doi">10.1073/pnas.1802177115</pub-id><pub-id pub-id-type="pmid">30082384</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>C</given-names></name><name><surname>Bengtsson-Palme</surname><given-names>J</given-names></name><name><surname>Kristiansson</surname><given-names>E</given-names></name><name><surname>Larsson</surname><given-names>DGJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Co-occurrence of resistance genes to antibiotics, biocides and metals reveals novel insights into their co-selection potential</article-title><source>BMC Genomics</source><volume>16</volume><elocation-id>964</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-015-2153-5</pub-id><pub-id pub-id-type="pmid">26576951</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>AE</given-names></name><name><surname>Thomas</surname><given-names>NE</given-names></name><name><surname>Morrison</surname><given-names>EA</given-names></name><name><surname>Balthazor</surname><given-names>BM</given-names></name><name><surname>Henzler-Wildman</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>New free-exchange model of EmrE transport</article-title><source>PNAS</source><volume>114</volume><fpage>E10083</fpage><lpage>E10091</lpage><pub-id pub-id-type="doi">10.1073/pnas.1708671114</pub-id><pub-id pub-id-type="pmid">29114048</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotem</surname><given-names>D</given-names></name><name><surname>Schuldiner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>EmrE, a multidrug transporter from <italic>Escherichia coli</italic>, transports monovalent and divalent substrates with the same stoichiometry</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>48787</fpage><lpage>48793</lpage><pub-id pub-id-type="doi">10.1074/jbc.M408187200</pub-id><pub-id pub-id-type="pmid">15371426</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotem</surname><given-names>D</given-names></name><name><surname>Steiner-Mordoch</surname><given-names>S</given-names></name><name><surname>Schuldiner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Identification of tyrosine residues critical for the function of an ion-coupled multidrug transporter</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>18715</fpage><lpage>18722</lpage><pub-id pub-id-type="doi">10.1074/jbc.M602088200</pub-id><pub-id pub-id-type="pmid">16672221</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria</article-title><source>Journal of Applied Microbiology</source><volume>92 Suppl</volume><fpage>121S</fpage><lpage>35S</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.92.5s1.12.x</pub-id><pub-id pub-id-type="pmid">12000621</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saleh</surname><given-names>M</given-names></name><name><surname>Bay</surname><given-names>DC</given-names></name><name><surname>Turner</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Few Conserved Amino Acids in the Small Multidrug Resistance Transporter EmrE Influence Drug Polyselectivity</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>62</volume><elocation-id>e00461-18</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.00461-18</pub-id><pub-id pub-id-type="pmid">29866867</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuldiner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>EmrE, a model for studying evolution and mechanism of ion-coupled transporters</article-title><source>Biochimica et Biophysica Acta</source><volume>1794</volume><fpage>748</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.1016/j.bbapap.2008.12.018</pub-id><pub-id pub-id-type="pmid">19167526</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sha</surname><given-names>F</given-names></name><name><surname>Salzman</surname><given-names>G</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Koide</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Monobodies and other synthetic binding proteins for expanding protein science</article-title><source>Protein Science</source><volume>26</volume><fpage>910</fpage><lpage>924</lpage><pub-id pub-id-type="doi">10.1002/pro.3148</pub-id><pub-id pub-id-type="pmid">28249355</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shcherbakov</surname><given-names>AA</given-names></name><name><surname>Hisao</surname><given-names>G</given-names></name><name><surname>Mandala</surname><given-names>VS</given-names></name><name><surname>Thomas</surname><given-names>NE</given-names></name><name><surname>Soltani</surname><given-names>M</given-names></name><name><surname>Salter</surname><given-names>EA</given-names></name><name><surname>Davis</surname><given-names>JH</given-names></name><name><surname>Henzler-Wildman</surname><given-names>KA</given-names></name><name><surname>Hong</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Structure and dynamics of the drug-bound bacterial transporter EmrE in lipid bilayers</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>172</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-20468-7</pub-id><pub-id pub-id-type="pmid">33420032</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soskine</surname><given-names>M</given-names></name><name><surname>Adam</surname><given-names>Y</given-names></name><name><surname>Schuldiner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Direct evidence for substrate-induced proton release in detergent-solubilized EmrE, a multidrug transporter</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>9951</fpage><lpage>9955</lpage><pub-id pub-id-type="doi">10.1074/jbc.M312853200</pub-id><pub-id pub-id-type="pmid">14701800</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tate</surname><given-names>CG</given-names></name><name><surname>Ubarretxena-Belandia</surname><given-names>I</given-names></name><name><surname>Baldwin</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Conformational changes in the multidrug transporter EmrE associated with substrate binding</article-title><source>Journal of Molecular Biology</source><volume>332</volume><fpage>229</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/s0022-2836(03)00895-7</pub-id><pub-id pub-id-type="pmid">12946360</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terwilliger</surname><given-names>TC</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>Afonine</surname><given-names>PV</given-names></name><name><surname>Moriarty</surname><given-names>NW</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Read</surname><given-names>RJ</given-names></name><name><surname>Zwart</surname><given-names>PH</given-names></name><name><surname>Hung</surname><given-names>LW</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Iterative-build OMIT maps: map improvement by iterative model building and refinement without model bias</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>64</volume><fpage>515</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1107/S0907444908004319</pub-id><pub-id pub-id-type="pmid">18453687</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>NE</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Morrison</surname><given-names>EA</given-names></name><name><surname>Robinson</surname><given-names>AE</given-names></name><name><surname>Werner</surname><given-names>JP</given-names></name><name><surname>Henzler-Wildman</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The C terminus of the bacterial multidrug transporter EmrE couples drug binding to proton release</article-title><source>Journal of Biological Chemistry</source><volume>293</volume><fpage>19137</fpage><lpage>19147</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA118.005430</pub-id><pub-id pub-id-type="pmid">30287687</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tickle</surname><given-names>IJ</given-names></name><name><surname>Flensburg</surname><given-names>C</given-names></name><name><surname>Keller</surname><given-names>P</given-names></name><name><surname>Paciorek</surname><given-names>W</given-names></name><name><surname>Sharff</surname><given-names>A</given-names></name><name><surname>Vonrhein</surname><given-names>C</given-names></name><name><surname>Bricogne</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><source>STARANISO</source><publisher-name>Global Phasing Ltd</publisher-name></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ubarretxena-Belandia</surname><given-names>I</given-names></name><name><surname>Baldwin</surname><given-names>JM</given-names></name><name><surname>Schuldiner</surname><given-names>S</given-names></name><name><surname>Tate</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Three-dimensional structure of the bacterial multidrug transporter EmrE shows it is an asymmetric homodimer</article-title><source>The EMBO Journal</source><volume>22</volume><fpage>6175</fpage><lpage>6181</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdg611</pub-id><pub-id pub-id-type="pmid">14633977</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vermaas</surname><given-names>JV</given-names></name><name><surname>Rempe</surname><given-names>SB</given-names></name><name><surname>Tajkhorshid</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Electrostatic lock in the transport cycle of the multidrug resistance transporter EmrE</article-title><source>PNAS</source><volume>115</volume><fpage>E7502</fpage><lpage>E7511</lpage><pub-id pub-id-type="doi">10.1073/pnas.1722399115</pub-id><pub-id pub-id-type="pmid">30026196</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>CJ</given-names></name><name><surname>Headd</surname><given-names>JJ</given-names></name><name><surname>Moriarty</surname><given-names>NW</given-names></name><name><surname>Prisant</surname><given-names>MG</given-names></name><name><surname>Videau</surname><given-names>LL</given-names></name><name><surname>Deis</surname><given-names>LN</given-names></name><name><surname>Verma</surname><given-names>V</given-names></name><name><surname>Keedy</surname><given-names>DA</given-names></name><name><surname>Hintze</surname><given-names>BJ</given-names></name><name><surname>Chen</surname><given-names>VB</given-names></name><name><surname>Jain</surname><given-names>S</given-names></name><name><surname>Lewis</surname><given-names>SM</given-names></name><name><surname>Arendall</surname><given-names>WB</given-names></name><name><surname>Snoeyink</surname><given-names>J</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Lovell</surname><given-names>SC</given-names></name><name><surname>Richardson</surname><given-names>JS</given-names></name><name><surname>Richardson</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>MolProbity: More and better reference data for improved all-atom structure validation</article-title><source>Protein Science</source><volume>27</volume><fpage>293</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1002/pro.3330</pub-id><pub-id pub-id-type="pmid">29067766</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilman</surname><given-names>HR</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Deane</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Helix kinks are equally prevalent in soluble and membrane proteins</article-title><source>Proteins</source><volume>82</volume><fpage>1960</fpage><lpage>1970</lpage><pub-id pub-id-type="doi">10.1002/prot.24550</pub-id><pub-id pub-id-type="pmid">24638929</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname><given-names>G</given-names></name><name><surname>Waterman</surname><given-names>DG</given-names></name><name><surname>Parkhurst</surname><given-names>JM</given-names></name><name><surname>Brewster</surname><given-names>AS</given-names></name><name><surname>Gildea</surname><given-names>RJ</given-names></name><name><surname>Gerstel</surname><given-names>M</given-names></name><name><surname>Fuentes-Montero</surname><given-names>L</given-names></name><name><surname>Vollmar</surname><given-names>M</given-names></name><name><surname>Michels-Clark</surname><given-names>T</given-names></name><name><surname>Young</surname><given-names>ID</given-names></name><name><surname>Sauter</surname><given-names>NK</given-names></name><name><surname>Evans</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>DIALS: implementation and evaluation of a new integration package</article-title><source>Acta Crystallographica. Section D, Structural Biology</source><volume>74</volume><fpage>85</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1107/S2059798317017235</pub-id><pub-id pub-id-type="pmid">29533234</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Wynne</surname><given-names>SA</given-names></name><name><surname>Thomas</surname><given-names>NE</given-names></name><name><surname>Uhlemann</surname><given-names>EM</given-names></name><name><surname>Tate</surname><given-names>CG</given-names></name><name><surname>Henzler-Wildman</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Identification of an Alternating-Access Dynamics Mutant of EmrE with Impaired Transport</article-title><source>Journal of Molecular Biology</source><volume>431</volume><fpage>2777</fpage><lpage>2789</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2019.05.035</pub-id><pub-id pub-id-type="pmid">31158365</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Frank</surname><given-names>AT</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>PyShifts: A PyMOL Plugin for Chemical Shift-Based Analysis of Biomolecular Ensembles</article-title><source>Journal of Chemical Information and Modeling</source><volume>60</volume><fpage>1073</fpage><lpage>1078</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.9b01039</pub-id><pub-id pub-id-type="pmid">32011127</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yerushalmi</surname><given-names>H</given-names></name><name><surname>Schuldiner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>An essential glutamyl residue in EmrE, a multidrug antiporter from <italic>Escherichia coli</italic></article-title><source>The Journal of Biological Chemistry</source><volume>275</volume><fpage>5264</fpage><lpage>5269</lpage><pub-id pub-id-type="doi">10.1074/jbc.275.8.5264</pub-id><pub-id pub-id-type="pmid">10681497</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>YG</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>CL</given-names></name><name><surname>Zhang</surname><given-names>SY</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>YS</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Gillings</surname><given-names>MR</given-names></name><name><surname>Su</surname><given-names>JQ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Continental-scale pollution of estuaries with antibiotic resistance genes</article-title><source>Nature Microbiology</source><volume>2</volume><elocation-id>16270</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.270</pub-id><pub-id pub-id-type="pmid">28134918</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76766.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ben-Tal</surname><given-names>Nir</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04mhzgx49</institution-id><institution>Tel Aviv University</institution></institution-wrap><country>Israel</country></aff></contrib></contrib-group></front-stub><body><p><italic>E. coli</italic> EmrE and other members of the SMR family of transporters utilize the proton motive force to pump out a broad spectrum of antibiotics, thereby contributing to multi-drug resistance. Here, a new multipurpose crystallization chaperone is used to determine the structure of EmrE in apo form and in complex with various substrates. The strength of the manuscript is in the description of six new structures of EmrE at a resolution sufficient for building an atomic model and understanding how the antimicrobial agents bind, allowing robust conclusions to be drawn regarding the molecular details of binding of the antimicrobial agents. The report will be of interest to both those studying antibiotic resistance and those studying transporters.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76766.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ben-Tal</surname><given-names>Nir</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04mhzgx49</institution-id><institution>Tel Aviv University</institution></institution-wrap><country>Israel</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Ben-Tal</surname><given-names>Nir</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04mhzgx49</institution-id><institution>Tel Aviv University</institution></institution-wrap><country>Israel</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Tate</surname><given-names>Christopher G</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00tw3jy02</institution-id><institution>MRC Laboratory of Molecular Biology</institution></institution-wrap><country>United Kingdom</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Henzler-Wildman</surname><given-names>Katherine A</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01gb8pc70</institution-id><institution>University of Wisconsin</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Crystal structures of bacterial Small Multidrug Resistance transporter EmrE in complex with structurally diverse substrates&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Nir Ben-Tal as Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Volker Dötsch as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Christopher G Tate (Reviewer #2); Katherine A Henzler-Wildman (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>We would appreciate more discussion of two points:</p><p>1. The L10 monobody has provided a valuable tool to facilitate structure determination of SMR family members, and we agree the EmrE mutations are likely not functionally significant. However, we would appreciate more discussion of the potential impact of monobody interaction itself on the EmrE structure, particularly in the loop regions. This was discussed in more detail in the prior Gdx-Clo structure paper from the Stockbridge group, but revisiting this is important here because of the role the loops play in closing off the transporter on one side of the membrane. Also, can this structure provide insight into how the L51I (and I62L) mutation near the end of TM2 (Lehninger <italic>eLife</italic> 2019;8:e48909) preferentially stabilizes EmrE in an open-to-one side conformation?</p><p>2. What is the exact pH at which each of the substrate-bound crystal structures were determined? The methods state that the substrate-bound structures (drug-like-substrate, proton is also a substrate) were crystallized at pH 6.5 or pH between 7.1-7.3 depending on the buffer. But we do not see the exact pH listed in the tables for each of the different crystal forms or discussed in the text. This information is important because of the proton-coupled transport mechanism.</p><p>The results state &quot;To understand how different substrates interact with EmrE, we screened a variety of transported compounds in crystallization trials at pH values {greater than or equal to} 6.5, where the E14 sidechains are expected to be deprotonated, favoring binding of the positively charged substrates.&quot; This is incorrect. For EmrE bound to tetraphenylphosphonium, the pKa of the E14 residue that remains protonatable 6.8 {plus minus} 0.1, thus crystallization conditions near neutral pH may result in a mixture of drug-substrate-bound and drug-substrate-plus-proton bound transporter. The pH values should be listed more explicitly for each structure and it would be helpful to discuss the implication of the pH for mechanistic interpretation of the structures.</p><p><italic>Reviewer #1:</italic></p><p>The discovery of the multi-drug resistant transporter EmrE years ago has raised hopes that, being significantly smaller than other multi-drug transporters, it can be used as a simple model. As it turned out, however, it has been rather difficult to figure out its transport mechanism, and until we (Fleishman et al., 2006) modeled its structure based on cryo-EM data, even its membrane topology (being dual) was unclear. Here, Stockbridge and colleagues finally managed to fulfill the early hopes. Taking advantage of a new in house developed multipurpose crystallization chaperone, they managed to determine the high-resolution structure of apo-EmrE as well as co-complexes with various substrates. Remarkably, they noticed that EmrE's backbone remain more or less unaltered and that the ability to accommodate chemically diverse substrates is mostly due to sidechains that change rotameric states. They also determined the structure of a homologue with less broad substrates spectrum and saw that compared to this reference transporter, whose binding site residues are held fixed by hydrogen bonds, EmrE's equivalent residues are engaged in much less hydrogen bonds and much more flexible.</p><p>Main strengths here are characterization of so many high-resolution structures of EmrE, and the addition of functional assays showing that the constructs used are functional and physiologically relevant. Additional strength is the clever use of these structures and the structures of the homologue to decipher the transport mechanism is detail. Finally, another strength is that the multipurpose crystallization chaperone may be useful for other members of the family, and the overall approach for other multi-drug transporters.<italic>Reviewer #2:</italic></p><p>The strength of the manuscript is in the description of six new structures of EmrE at a resolution sufficient for building an atomic model and understanding how the antimicrobial agents bind. What is notable is that the X-ray structures fit extremely well to a low resolution density map of EmrE determined by electron cryo-microscopy of the transporter embedded in a lipid bilayer, suggesting that the structure is a good representation of a physiologically relevant state. This is in contrast to a recently determined NMR structure of EmrE that does not fit the density so well. The quality of the X-ray structures allows the positions of amino acid side chains to be determined, thus allowing robust conclusions to be drawn regarding the molecular details of binding of the antimicrobial agents. The results are supported by extensive previously published work on EmrE performed by site-directed mutagenesis and activity assays. The manuscript is very clearly written and presented. I do not find any significant weaknesses in the manuscript.</p><p><italic>Reviewer #3:</italic></p><p>This work builds on the Stockbridge previous efforts to determine the structure of Gdx, an SMR homolog that has a much narrower substrate profile and functions as a toxic metabolite exporter (specifically guanidinium), rather than promiscuous toxin exporter like EmrE. Strength of the work is the large number of structures for EmrE, the SMR for which the function and transport mechanism has been most extensively studied. Structural data is important for understanding the molecular basis for promiscuous multidrug recognition and transport.</p><p>Given the resolution is in the 3-4Å range for the substrate bound structures, it is important to examine the density of not just the substrate, but also key sidechains in the active site when assessing how EmrE binds different substrates. I appreciate that this density is shown for the higher resolution TPP+ and methyl viologen bound structures to really demonstrate the strength of the conclusions that E14 and W63 change position to accommodate planar vs tetrahedral substrates.</p><p>Another strength is the comparison of the low pH EmrE and Gdx structures illustrating the difference in hydrogen bonding network within the central pore region, and the insights this provides into the difference in side chain orientations and promiscuity of these two homologous transporters. These insights into the substrate recognition mechanisms are important for understanding the divergence of the two SMR transporter subfamilies and may be helpful for understanding how proteins achieve promiscuous vs specific binding more broadly.</p><p>Two areas require further detail and discussion to be added to the manuscript:</p><p>1. While I agree that the L10 monobody has provided a valuable tool to facilitate structure determination of SMR family members, and the individual point mutations made to enable monobody binding are unlikely to cause significant functional or structural defects in EmrE, I would appreciate more discussion of the potential impact of the monobody on EmrE structure? The comparison with prior EM data is consistent with the monobody not having a significant impact on the overall arrangement of transmembrane helices, but I am more concerned with potential impact on the flexible loop regions. This was discussed in more detail in the prior Gdx-Clo structure paper from the Stockbridge group, but revisiting this is important here. This is particularly relevant because of the role the loops play in closing off the transporter on one side of the membrane. Figures highlighting the density of the loop regions on both the closed and open face of the transporter with the monobody interactions highlighted would be helpful in assessing this. In addition, it would be worthwhile to consider whether this structure can provide insight into how the L51I (and I62L) mutation near the end of TM2 (Lehninger <italic>eLife</italic> 2019;8:e48909) preferentially stabilizes EmrE in an open-to-one side conformation.</p><p>2. What is the exact pH at which each of the substrate-bound crystal structures were determined? The pH of the apo crystal structure is listed in the tables and discussed in the text of the manuscript, highlighting that this is a low-pH structure and thus represents the proton-bound state of the transporter (not truly apo). The methods state that the (drug-like, proton is also a substrate) substrate-bound structures were crystallized at pH 6.5 or pH between 7.1-7.3 depending on the buffer. But I do not see the exact pH listed in the tables for each of the different crystal forms or discussed in the text. This information is important because EmrE is a proton-coupled transporter.</p><p>The results state &quot;To understand how different substrates interact with EmrE, we screened a variety of transported compounds in crystallization trials at pH values {greater than or equal to} 6.5, where the E14 sidechains are expected to be deprotonated, favoring binding of the positively charged substrates.&quot; This is not correct. The pKa values of E14 in drug-free EmrE are 7.0 and 8.2 at 25 {degree sign}C (Morrison, J Gen Phys 2015, 146:445). EmrE is able to bind drug-like substrate and proton simultaneously, although only one of the E14 remains protonatable (Robinson, PNAS 2017, 114:E10083). For EmrE bound to tetraphenylphosphonium, the pKa of the E14 residue that remains protonatable 6.8 {plus minus} 0.1, thus crystallization conditions near neutral pH may result in a mixture of drug-substrate-bound and drug-substrate-plus-proton bound transporter.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76766.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>We would appreciate more discussion of two points:</p><p>1. The L10 monobody has provided a valuable tool to facilitate structure determination of SMR family members, and we agree the EmrE mutations are likely not functionally significant. However, we would appreciate more discussion of the potential impact of monobody interaction itself on the EmrE structure, particularly in the loop regions.</p></disp-quote><p>We have added a comment to this paragraph commenting on the loops explicitly:</p><p>“However, two lines of evidence disfavor the possibility that the monobody-bound state is aberrant. First, we showed that monobody binding has only a minor effect on transport function, and second, our model corresponds closely to the helix density in the EM dataset, which was obtained without exogenous binding proteins(Ubarretxena-Belandia et al., 2003). Although local perturbations at the monobody-binding interface of loops 1<sub>A</sub> and 1<sub>B</sub> cannot be ruled out, the position of loop 1<sub>A</sub> is consistent with prior spectroscopic data, which indicated that in the major solution conformation, F27<sub>A</sub> packs against the B subunit with its sidechain oriented towards the substrate binding site. Loop 1<sub>B</sub> is located on the open side of the transporter and does not form any intra-transporter contacts. Therefore, even if monobody does stabilize a less-prevalent conformation of loop 1<sub>B</sub>, this would not change the major interpretations of the present structures.”</p><disp-quote content-type="editor-comment"><p>This was discussed in more detail in the prior Gdx-Clo structure paper from the Stockbridge group, but revisiting this is important here because of the role the loops play in closing off the transporter on one side of the membrane. Also, can this structure provide insight into how the L51I (and I62L) mutation near the end of TM2 (Lehninger eLife 2019;8:e48909) preferentially stabilizes EmrE in an open-to-one side conformation?</p></disp-quote><p>We have added the following paragraph to the discussion:</p><p>“Our results also provide some insight into the observation that a single L51I or I62L mutation in one subunit of the EmrE dimer prevents conformational exchange (Leninger et al., 2019). Both residues are located on transmembrane helices and are buried at protein interfaces in one monomer and accessible in the other (L51 to the aqueous binding pocket and I62 to the membrane). For Gdx-Clo, we previously posited that differential packing of the two monomers in the N-terminal half of helix 3 contributes to structural frustration and the resulting conformational exchange (Kermani et al., 2020). In EmrE, I62 is located in this same crucial region, and its mutation in only one monomer presumably disturbs the well-matched competition that occurs in the homodimer.<italic>”</italic></p><disp-quote content-type="editor-comment"><p>2. What is the exact pH at which each of the substrate-bound crystal structures were determined? The methods state that the substrate-bound structures (drug-like-substrate, proton is also a substrate) were crystallized at pH 6.5 or pH between 7.1-7.3 depending on the buffer. But we do not see the exact pH listed in the tables for each of the different crystal forms or discussed in the text. This information is important because of the proton-coupled transport mechanism.</p><p>The results state &quot;To understand how different substrates interact with EmrE, we screened a variety of transported compounds in crystallization trials at pH values {greater than or equal to}6.5, where the E14 sidechains are expected to be deprotonated, favoring binding of the positively charged substrates.&quot; This is incorrect.</p></disp-quote><p>We have added the crystallization conditions for each structure to the data collection and refinement table (Table 1).</p><p>We have removed this sentence from the results. In the discussion, we elaborated on the interplay of pH and substrate binding as follows:</p><p>“In addition to a substrate-free, pH 5.2 structure, we solved structures of EmrE with methyl viologen, harmane, Me-TPP<sup>+</sup>, TPP<sup>+</sup>, and benzyltrimethylammonium at pH values between 6.3 and 7.5. Experiments with EmrE in bicelles have suggested that a proton can bind simultaneously with TPP<sup>+</sup> with a pK<sub>a</sub> of 6.8 (Robinson et al., 2017). In the NMR model, under conditions that favor simultaneous substrate and proton binding, F-TPP<sup>+</sup> is positioned higher in the binding pocket, 2 Å closer to E14<sub>B</sub> than protonated E14<sub>A</sub> (Shcherbakov et al., 2021). In contrast, in our TPP<sup>+</sup>-bound structure, which was obtained at a pH of 7.25, TPP<sup>+</sup> is situated lower in the binding pocket and within 0.5 Å of the midpoint between the glutamates. It is thus probable that this crystal structure represents the doubly-deprotonated, substrate-bound state. It is also likely that both glutamates are deprotonated in the methyl viologen-bound structure, since this substrate bears a +2 charge, making glutamate protonation more electrostatically unfavorable than in the presence of a monovalent substrate.</p><p>Protonation of the central glutamates has not been evaluated in the presence of monovalent substrates other than TPP<sup>+</sup>, and the E14 pK<sub>a</sub> values are likely to vary according to factors such as binding pocket solvation or charge delocalization on the substrate. For the Me-TPP<sup>+</sup>, harmane, and benzyltrimethylammonium-bound structures (pH 6.5, 7.1, and 7.25, respectively), the contribution of a substrate+proton-bound population cannot be ruled out. However, the positioning of each of these substrates centered close to the midpoint between the E14 carboxylate groups, similar to TPP<sup>+</sup>, implies that in the major component of the population, both glutamates bear a negative charge.”</p></body></sub-article></article>